Global Biobanks Market: By Product & Service, By Sample Type, By Storage Type, By Ownership, By Application, By End-User, By Region & Segmental Insights Trends and Forecast, 2024 – 2034

  • Industry: Healthcare
  • Report ID: TNR-110-1098
  • Number of Pages: 420
  • Table/Charts : Yes
  • May, 2024
  • Base Year : 2024
  • No. of Companies : 10+
  • No. of Countries : 29
  • Views : 10053
  • Covid Impact Covered: Yes
  • War Impact Covered: Yes
  • Formats : PDF, Excel, PPT

Biobanks are specialized facilities that store and manage biological samples, such as tissues, blood, cells, DNA, and other bodily fluids, along with associated clinical and demographic data. These repositories play a crucial role in biomedical research, translational medicine, and personalized healthcare by providing researchers, clinicians, and pharmaceutical companies with access to high-quality biospecimens for various applications.

Biobanks support basic, translational, and clinical research by providing researchers with access to well-characterized biospecimens and associated data. These resources facilitate studies aimed at understanding the molecular mechanisms of diseases, identifying biomarkers for early detection and diagnosis, elucidating disease progression, and developing new therapeutic interventions. Biobanks contribute to the drug discovery and development process by supplying researchers and pharmaceutical companies with the biological materials needed to identify and validate potential drug targets, evaluate drug efficacy and safety, conduct preclinical and clinical trials, and assess drug responses in patient populations. In terms of revenue, the global biobanks market was worth US$ 81.22 Bn in 2023, anticipated to witness CAGR of 11.1% During 2024 – 2034.

Global Biobanks Market Dynamics

Increasing Demand for Personalized Medicine: The growing emphasis on personalized medicine and precision healthcare has fuelled the demand for high-quality biospecimens and associated clinical data for research and therapeutic development. Biobanks play a crucial role in collecting, storing, and distributing biological samples and related information to support translational research, biomarker discovery, and drug development efforts aimed at delivering targeted therapies and interventions tailored to individual patient profiles.

Rapid Advancements in Biomedical Research: Technological advancements in genomics, proteomics, and other omics disciplines have accelerated biomedical research initiatives focused on understanding the molecular basis of diseases and identifying potential therapeutic targets. Biobanks serve as valuable repositories of well-characterized biospecimens and longitudinal health data, enabling researchers to conduct large-scale epidemiological studies, genome-wide association studies (GWAS), and multi-omics analyses to elucidate disease mechanisms, identify biomarkers, and develop novel diagnostic tools and treatments.

Equipment has Gained Popularity in the Recent Years and Has garnered major market share in the Global Biobanks Market During the Forecast Period (2024 – 2034).

Biobanks require specialized equipment for sample processing tasks such as centrifugation, aliquoting, Labeling, and preservation. High-throughput automated systems and robotic platforms enhance the efficiency and accuracy of sample handling procedures, allowing biobanks to process large volumes of samples quickly and consistently. Demand for equipment that enables streamlined sample processing workflows is driven by the need to optimize resource utilization, minimize manual errors, and accelerate sample turnaround times. Proper storage conditions are critical for maintaining sample integrity and stability over time. Biobanks invest in equipment such as ultra-low temperature freezers, cryogenic storage systems, and automated sample retrieval systems to ensure optimal storage conditions for various sample types, including tissues, blood, cells, and DNA. Demand for reliable and energy-efficient storage solutions is driven by the need to preserve sample quality, minimize sample degradation, and comply with regulatory requirements governing sample storage and tracking.

By Sample Type Blood Products Segment had the Highest Share in the Global Biobanks Market in 2023.

The Blood Product segment dominated the global Biobanks market, in terms of revenue and is estimated to sustain its dominance over the forecast period.  Blood products obtained from biobanks are essential for various clinical applications, including transfusions for patients undergoing surgeries, cancer treatments, organ transplants, and management of blood disorders such as anaemia and haemophilia. The availability of a diverse range of blood products ensures that healthcare providers can meet the needs of patients with different medical conditions. Biobanks serve as valuable resources for biomedical research aimed at understanding the physiology of blood, identifying disease biomarkers, developing new diagnostic tests, and discovering novel therapies. Blood samples stored in biobanks are used in studies investigating the genetic basis of diseases, pharmacogenomics, and population health research, among other areas. The demand for blood products from biobanks is driven by the need for high-quality samples to support research initiatives.

By End User Pharmaceutical & Biotechnology Companies and CROs has the Highest Share in the Global Biobanks Market in 2023.

Pharmaceutical and biotechnology companies conduct extensive research and development (R&D) activities to discover and develop new drugs, therapies, and medical products. Biobanks provide these companies with access to high-quality human biological samples, including tissues, blood, cells, and DNA, which are essential for conducting preclinical studies, biomarker discovery, target validation, and clinical trials. The availability of well-characterized and ethically sourced samples from diverse populations is crucial for accelerating the drug development process. With the rise of precision medicine approaches, pharmaceutical and biotechnology companies are increasingly focusing on developing targeted therapies and personalized treatments tailored to individual patients. Biobanks play a critical role in supporting precision medicine initiatives by providing access to longitudinal patient samples, clinical data, and genetic information. By analyzing these resources, companies can identify genetic markers, biomarkers, and therapeutic targets associated with specific diseases or patient subpopulations, leading to the development of more effective and personalized treatments.

North America has garnered major market share in 2023 accounting for ~43.5% in the global biobanks market. North America is home to numerous pharmaceutical, biotechnology, and research institutions that are actively engaged in drug discovery, development, and clinical research. Biobanks play a crucial role in supporting these efforts by providing researchers with access to high-quality biological samples, such as tissue, blood, and DNA, along with associated clinical and demographic data. The adoption of precision medicine approaches, which aim to tailor medical treatments to individual patients based on their genetic makeup, is driving the demand for biobanks in North America. Biobanks serve as repositories of diverse biological samples and molecular data, enabling researchers and clinicians to study the genetic basis of diseases, identify biomarkers, and develop personalized therapies. The rapid advancements in genomics, proteomics, and other omics technologies have generated vast amounts of biological data that require comprehensive storage and management solutions. Biobanks provide a centralized platform for storing, cataloging, and sharing biological samples and associated data, facilitating collaborative research and data-driven discoveries.

Competitive Landscape: Global Biobanks Market:

  • Avantor Inc.
  • Azenta Inc
  • Becton Dickinson and Company
  • Cryoport Inc.
  • Hamilton Company
  • Merck & Co., Inc.
  • PHC Holdings Corporation
  • Qiagen N.V.
  • Tecan Trading AG
  • Thermo Fisher Scientific, Inc.
  • Other Industry Participants

Global Biobanks Market: Key Takeaway

Report Specifications Details
Market Revenue in 2023 US$ 81.22 Bn
Market Size Forecast by 2034 US$ 167.99 Bn
Growth Rate (CAGR) 11.1%
Historic Data 2016 – 2022
Base Year for Estimation 2023
Forecast Period 2024 – 2034
Report Inclusions Market Size & Estimates, Market Dynamics, Competitive Scenario, Trends, Growth Factors, Market Determinants, Key Investment Segmentation, Product/Service/Solutions Benchmarking
Segments Covered By Product & Service, By Sample Type, By Storage Type, By Ownership, By Application, By End-User
Regions Covered North America, Europe, Asia Pacific, Middle East & Africa, Latin America
Countries Covered U.S., Canada, Mexico, Rest of North America,  France, The UK, Spain, Germany, Italy, Nordic Countries (Denmark, Finland, Iceland, Sweden, Norway), Benelux Union (Belgium, The Netherlands, Luxembourg), Rest of Europe,  China, Japan, India, New Zealand, Australia, South Korea, Southeast Asia (Indonesia, Thailand, Malaysia, Singapore, Rest of Southeast Asia), Rest of Asia Pacific,  Saudi Arabia, UAE, Egypt, Kuwait, South Africa, Rest of Middle East & Africa,  Brazil, Argentina, Rest of Latin America
Key Players Avantor Inc, Azenta Inc, Becton Dickinson and Company, Cryoport Inc., Hamilton Company, Merck & Co., Inc., PHC Holdings Corporation, Qiagen N.V., Tecan Trading AG, Thermo Fisher Scientific, Inc., Other Industry Participants
Customization Scope Customization allows for the inclusion/modification of content pertaining to geographical regions, countries, and specific market segments.
Pricing & Procurement Options Explore purchase options tailored to your specific research requirements
Contact Details Consult With Our Expert

Japan (Toll-Free):  +81 663-386-8111

South Korea (Toll-Free):  +82-808- 703-126

Saudi Arabia (Toll-Free):  +966 800-850-1643

United Kingdom: +44 753-710-5080

United States: +1 302-232-5106

E-mail:  askanexpert@thenicheresearch.com

Global Biobanks Market

By Product & Service

  • Equipment
    • Storage Equipment
    • Sample Analysis Equipment
    • Sample Processing Equipment
    • Sample Transport Equipment
  • Consumables
    • Storage Consumables
    • Analysis Consumables
    • Processing Consumables
    • Collection Consumables
  • Services
    • Storage Services
    • Processing Services
    • Transport Services
    • Supply Services
  • Software

By Sample Type

  • Blood Products
  • Human Tissues
  • Cell Lines
  • Nucleic Acids
  • Biological Fluids
  • Human Waste product

By Storage Type

  • Manual Storage
  • Automated Storage

By Ownership

  • Universities
  • National/ Regional agencies
  • Non-Profit Organization
  • Private organization

By Application

  • Regenerative Medicine
  • Life Science Research
  • Clinical Research

By End-User

  • Pharmaceutical & Biotechnology Companies and CROs
  • Academic & Research Institutes
  • Hospitals

By Region

  • North America (U.S., Canada, Mexico, Rest of North America)
  • Europe (France, The UK, Spain, Germany, Italy, Nordic Countries (Denmark, Finland, Iceland, Sweden, Norway), Benelux Union (Belgium, The Netherlands, Luxembourg), Rest of Europe
  • Asia Pacific (China, Japan, India, New Zealand, Australia, South Korea, Southeast Asia (Indonesia, Thailand, Malaysia, Singapore, Rest of Southeast Asia), Rest of Asia Pacific
  • Middle East & Africa (Saudi Arabia, UAE, Egypt, Kuwait, South Africa, Rest of Middle East & Africa)
  • Latin America (Brazil, Argentina, Rest of Latin America)

Report Layout:

 

Table of Contents

.

1.Market Scope
1.1.Market Segmentation

1.2.Years Considered
1.2.1.Historic Years: 2016 – 2022

1.2.2.Base Year: 2023

1.2.3.Forecast Years: 2024 – 2034

2.Key Target Audiences

3.Research Methodology
3.1.Primary Research
3.1.1.Research Questionnaire

3.1.2.Global Percentage Breakdown

3.1.3.Primary Interviews: Key Opinion Leaders (KOLs)

3.2.Secondary Research
3.2.1.Paid Databases

3.2.2.Secondary Sources

3.3.Market Size Estimates
3.3.1.Top-Down Approach

3.3.2.Bottom-Up Approach

3.4.Data Triangulation Methodology

3.5.Research Assumptions

4.Recommendations and Insights from TNR’s Perspective**

5.Holistic Overview of Biobanks Market

6.Market Synopsis: Biobanks Market

7.Biobanks Market Analysis: Qualitative Perspective
7.1.Introduction
7.1.1.Product Definition

7.1.2.Industry Development

7.2.Market Dynamics
7.2.1.Drivers

7.2.2.Restraints

7.2.3.Opportunities

7.2.4.Challenges

7.3.Trends in Biobanks Market

7.4.Market Determinants Radar Chart

7.5.Macro-Economic and Micro-Economic Indicators: Biobanks Market

7.6.Porter’s Five Force Analysis

7.7.Impact of Covid-19 on Biobanks Market

7.8.PESTEL Analysis

8.Global Biobanks Market Analysis and Forecasts, 2024 – 2034
8.1.Overview
8.1.1.Global Biobanks Market Revenue (US$ Mn)

8.2.Global Biobanks Market Revenue (US$ Mn) and Forecasts, By Product and Services
8.2.1.Equipment (Definition, Market Estimation and Penetration, 2016 – 2023, Market Estimation (2016 – 2023), Market Forecast (2024 – 2034), Compound Annual Growth Rate (CAGR), Regional Bifurcation (North America, Europe, Asia Pacific, Middle East and Africa, Latin America) and Information on Storage Equipment, Sample Analysis Equipment, Sample Processing Equipment, Sample Transport Equipment)
8.2.1.1.Storage Equipment

8.2.1.2.Sample Analysis Equipment

8.2.1.3.Sample Processing Equipment

8.2.1.4.Sample Transport Equipment

8.2.2.Consumables (Definition, Market Estimation and Penetration, 2016 – 2023, Market Estimation (2016 – 2023), Market Forecast (2024 – 2034), Compound Annual Growth Rate (CAGR), Regional Bifurcation (North America, Europe, Asia Pacific, Middle East and Africa, Latin America) and Information on Storage Consumables, Analysis Consumables, Processing Consumables, Collection Consumables)
8.2.2.1.Storage Consumables

8.2.2.2.Analysis Consumables

8.2.2.3.Processing Consumables

8.2.2.4.Collection Consumables

8.2.3.Services (Definition, Market Estimation and Penetration, 2016 – 2023, Market Estimation (2016 – 2023), Market Forecast (2024 – 2034), Compound Annual Growth Rate (CAGR), Regional Bifurcation (North America, Europe, Asia Pacific, Middle East and Africa, Latin America) and Information on Storage Services, Processing Services, Transport Services, Supply Services)
8.2.3.1.Storage Services

8.2.3.2.Processing Services

8.2.3.3.Transport Services

8.2.3.4.Supply Services

8.2.4.Software
8.2.4.1.Definition

8.2.4.2.Market Estimation and Penetration, 2016 – 2023

8.2.4.3.Market Forecast, 2024 – 2034

8.2.4.4.Compound Annual Growth Rate (CAGR)

8.2.4.5.Regional Bifurcation
8.2.4.5.1.North America
8.2.4.5.1.1.Market Estimation, 2016 – 2023

8.2.4.5.1.2.Market Forecast, 2024 – 2034

8.2.4.5.2.Europe
8.2.4.5.2.1.Market Estimation, 2016 – 2023

8.2.4.5.2.2.Market Forecast, 2024 – 2034

8.2.4.5.3.Asia Pacific
8.2.4.5.3.1.Market Estimation, 2016 – 2023

8.2.4.5.3.2.Market Forecast, 2024 – 2034

8.2.4.5.4.Middle East and Africa
8.2.4.5.4.1.Market Estimation, 2016 – 2023

8.2.4.5.4.2.Market Forecast, 2024 – 2034

8.2.4.5.5.Latin America
8.2.4.5.5.1.Market Estimation, 2016 – 2023

8.2.4.5.5.2.Market Forecast, 2024 – 2034

8.3.Key Segment for Channeling Investments
8.3.1.By Product and Services

9.Global Biobanks Market Analysis and Forecasts, 2024 – 2034
9.1.Overview

9.2.Global Biobanks Market Revenue (US$ Mn) and Forecasts, By Sample Type
9.2.1.Blood Products
9.2.1.1.Definition

9.2.1.2.Market Estimation and Penetration, 2016 – 2023

9.2.1.3.Market Forecast, 2024 – 2034

9.2.1.4.Compound Annual Growth Rate (CAGR)

9.2.1.5.Regional Bifurcation
9.2.1.5.1.North America
9.2.1.5.1.1.Market Estimation, 2016 – 2023

9.2.1.5.1.2.Market Forecast, 2024 – 2034

9.2.1.5.2.Europe
9.2.1.5.2.1.Market Estimation, 2016 – 2023

9.2.1.5.2.2.Market Forecast, 2024 – 2034

9.2.1.5.3.Asia Pacific
9.2.1.5.3.1.Market Estimation, 2016 – 2023

9.2.1.5.3.2.Market Forecast, 2024 – 2034

9.2.1.5.4.Middle East and Africa
9.2.1.5.4.1.Market Estimation, 2016 – 2023

9.2.1.5.4.2.Market Forecast, 2024 – 2034

9.2.1.5.5.Latin America
9.2.1.5.5.1.Market Estimation, 2016 – 2023

9.2.1.5.5.2.Market Forecast, 2024 – 2034

9.2.2.Human Tissues
9.2.2.1.Definition

9.2.2.2.Market Estimation and Penetration, 2016 – 2023

9.2.2.3.Market Forecast, 2024 – 2034

9.2.2.4.Compound Annual Growth Rate (CAGR)

9.2.2.5.Regional Bifurcation
9.2.2.5.1.North America
9.2.2.5.1.1.Market Estimation, 2016 – 2023

9.2.2.5.1.2.Market Forecast, 2024 – 2034

9.2.2.5.2.Europe
9.2.2.5.2.1.Market Estimation, 2016 – 2023

9.2.2.5.2.2.Market Forecast, 2024 – 2034

9.2.2.5.3.Asia Pacific
9.2.2.5.3.1.Market Estimation, 2016 – 2023

9.2.2.5.3.2.Market Forecast, 2024 – 2034

9.2.2.5.4.Middle East and Africa
9.2.2.5.4.1.Market Estimation, 2016 – 2023

9.2.2.5.4.2.Market Forecast, 2024 – 2034

9.2.2.5.5.Latin America
9.2.2.5.5.1.Market Estimation, 2016 – 2023

9.2.2.5.5.2.Market Forecast, 2024 – 2034

9.2.3.Cell Lines
9.2.3.1.Definition

9.2.3.2.Market Estimation and Penetration, 2016 – 2023

9.2.3.3.Market Forecast, 2024 – 2034

9.2.3.4.Compound Annual Growth Rate (CAGR)

9.2.3.5.Regional Bifurcation
9.2.3.5.1.North America
9.2.3.5.1.1.Market Estimation, 2016 – 2023

9.2.3.5.1.2.Market Forecast, 2024 – 2034

9.2.3.5.2.Europe
9.2.3.5.2.1.Market Estimation, 2016 – 2023

9.2.3.5.2.2.Market Forecast, 2024 – 2034

9.2.3.5.3.Asia Pacific
9.2.3.5.3.1.Market Estimation, 2016 – 2023

9.2.3.5.3.2.Market Forecast, 2024 – 2034

9.2.3.5.4.Middle East and Africa
9.2.3.5.4.1.Market Estimation, 2016 – 2023

9.2.3.5.4.2.Market Forecast, 2024 – 2034

9.2.3.5.5.Latin America
9.2.3.5.5.1.Market Estimation, 2016 – 2023

9.2.3.5.5.2.Market Forecast, 2024 – 2034

9.2.4.Nucleic Acids
9.2.4.1.Definition

9.2.4.2.Market Estimation and Penetration, 2016 – 2023

9.2.4.3.Market Forecast, 2024 – 2034

9.2.4.4.Compound Annual Growth Rate (CAGR)

9.2.4.5.Regional Bifurcation
9.2.4.5.1.North America
9.2.4.5.1.1.Market Estimation, 2016 – 2023

9.2.4.5.1.2.Market Forecast, 2024 – 2034

9.2.4.5.2.Europe
9.2.4.5.2.1.Market Estimation, 2016 – 2023

9.2.4.5.2.2.Market Forecast, 2024 – 2034

9.2.4.5.3.Asia Pacific
9.2.4.5.3.1.Market Estimation, 2016 – 2023

9.2.4.5.3.2.Market Forecast, 2024 – 2034

9.2.4.5.4.Middle East and Africa
9.2.4.5.4.1.Market Estimation, 2016 – 2023

9.2.4.5.4.2.Market Forecast, 2024 – 2034

9.2.4.5.5.Latin America
9.2.4.5.5.1.Market Estimation, 2016 – 2023

9.2.4.5.5.2.Market Forecast, 2024 – 2034

9.2.5.Biological Fluids
9.2.5.1.Definition

9.2.5.2.Market Estimation and Penetration, 2016 – 2023

9.2.5.3.Market Forecast, 2024 – 2034

9.2.5.4.Compound Annual Growth Rate (CAGR)

9.2.5.5.Regional Bifurcation
9.2.5.5.1.North America
9.2.5.5.1.1.Market Estimation, 2016 – 2023

9.2.5.5.1.2.Market Forecast, 2024 – 2034

9.2.5.5.2.Europe
9.2.5.5.2.1.Market Estimation, 2016 – 2023

9.2.5.5.2.2.Market Forecast, 2024 – 2034

9.2.5.5.3.Asia Pacific
9.2.5.5.3.1.Market Estimation, 2016 – 2023

9.2.5.5.3.2.Market Forecast, 2024 – 2034

9.2.5.5.4.Middle East and Africa
9.2.5.5.4.1.Market Estimation, 2016 – 2023

9.2.5.5.4.2.Market Forecast, 2024 – 2034

9.2.5.5.5.Latin America
9.2.5.5.5.1.Market Estimation, 2016 – 2023

9.2.5.5.5.2.Market Forecast, 2024 – 2034

9.2.6.Human Waste Product
9.2.6.1.Definition

9.2.6.2.Market Estimation and Penetration, 2016 – 2023

9.2.6.3.Market Forecast, 2024 – 2034

9.2.6.4.Compound Annual Growth Rate (CAGR)

9.2.6.5.Regional Bifurcation
9.2.6.5.1.North America
9.2.6.5.1.1.Market Estimation, 2016 – 2023

9.2.6.5.1.2.Market Forecast, 2024 – 2034

9.2.6.5.2.Europe
9.2.6.5.2.1.Market Estimation, 2016 – 2023

9.2.6.5.2.2.Market Forecast, 2024 – 2034

9.2.6.5.3.Asia Pacific
9.2.6.5.3.1.Market Estimation, 2016 – 2023

9.2.6.5.3.2.Market Forecast, 2024 – 2034

9.2.6.5.4.Middle East and Africa
9.2.6.5.4.1.Market Estimation, 2016 – 2023

9.2.6.5.4.2.Market Forecast, 2024 – 2034

9.2.6.5.5.Latin America
9.2.6.5.5.1.Market Estimation, 2016 – 2023

9.2.6.5.5.2.Market Forecast, 2024 – 2034

9.3.Key Segment for Channeling Investments
9.3.1.By Sample Type

10.Global Biobanks Market Analysis and Forecasts, 2024 – 2034
10.1.Overview

10.2.Global Biobanks Market Revenue (US$ Mn) and Forecasts, By Storage Type
10.2.1.Manual Storage
10.2.1.1.Definition

10.2.1.2.Market Estimation and Penetration, 2016 – 2023

10.2.1.3.Market Forecast, 2024 – 2034

10.2.1.4.Compound Annual Growth Rate (CAGR)

10.2.1.5.Regional Bifurcation
10.2.1.5.1.North America
10.2.1.5.1.1.Market Estimation, 2016 – 2023

10.2.1.5.1.2.Market Forecast, 2024 – 2034

10.2.1.5.2.Europe
10.2.1.5.2.1.Market Estimation, 2016 – 2023

10.2.1.5.2.2.Market Forecast, 2024 – 2034

10.2.1.5.3.Asia Pacific
10.2.1.5.3.1.Market Estimation, 2016 – 2023

10.2.1.5.3.2.Market Forecast, 2024 – 2034

10.2.1.5.4.Middle East and Africa
10.2.1.5.4.1.Market Estimation, 2016 – 2023

10.2.1.5.4.2.Market Forecast, 2024 – 2034

10.2.1.5.5.Latin America
10.2.1.5.5.1.Market Estimation, 2016 – 2023

10.2.1.5.5.2.Market Forecast, 2024 – 2034

10.2.2.Automated Storage
10.2.2.1.Definition

10.2.2.2.Market Estimation and Penetration, 2016 – 2023

10.2.2.3.Market Forecast, 2024 – 2034

10.2.2.4.Compound Annual Growth Rate (CAGR)

10.2.2.5.Regional Bifurcation
10.2.2.5.1.North America
10.2.2.5.1.1.Market Estimation, 2016 – 2023

10.2.2.5.1.2.Market Forecast, 2024 – 2034

10.2.2.5.2.Europe
10.2.2.5.2.1.Market Estimation, 2016 – 2023

10.2.2.5.2.2.Market Forecast, 2024 – 2034

10.2.2.5.3.Asia Pacific
10.2.2.5.3.1.Market Estimation, 2016 – 2023

10.2.2.5.3.2.Market Forecast, 2024 – 2034

10.2.2.5.4.Middle East and Africa
10.2.2.5.4.1.Market Estimation, 2016 – 2023

10.2.2.5.4.2.Market Forecast, 2024 – 2034

10.2.2.5.5.Latin America
10.2.2.5.5.1.Market Estimation, 2016 – 2023

10.2.2.5.5.2.Market Forecast, 2024 – 2034

10.3.Key Segment for Channeling Investments
10.3.1.By Storage Type

11.Global Biobanks Market Analysis and Forecasts, 2024 – 2034
11.1.Overview

11.2.Global Biobanks Market Revenue (US$ Mn) and Forecasts, By Ownership
11.2.1.Universities
11.2.1.1.Definition

11.2.1.2.Market Estimation and Penetration, 2016 – 2023

11.2.1.3.Market Forecast, 2024 – 2034

11.2.1.4.Compound Annual Growth Rate (CAGR)

11.2.1.5.Regional Bifurcation
11.2.1.5.1.North America
11.2.1.5.1.1.Market Estimation, 2016 – 2023

11.2.1.5.1.2.Market Forecast, 2024 – 2034

11.2.1.5.2.Europe
11.2.1.5.2.1.Market Estimation, 2016 – 2023

11.2.1.5.2.2.Market Forecast, 2024 – 2034

11.2.1.5.3.Asia Pacific
11.2.1.5.3.1.Market Estimation, 2016 – 2023

11.2.1.5.3.2.Market Forecast, 2024 – 2034

11.2.1.5.4.Middle East and Africa
11.2.1.5.4.1.Market Estimation, 2016 – 2023

11.2.1.5.4.2.Market Forecast, 2024 – 2034

11.2.1.5.5.Latin America
11.2.1.5.5.1.Market Estimation, 2016 – 2023

11.2.1.5.5.2.Market Forecast, 2024 – 2034

11.2.2.National/ Regional Agencies
11.2.2.1.Definition

11.2.2.2.Market Estimation and Penetration, 2016 – 2023

11.2.2.3.Market Forecast, 2024 – 2034

11.2.2.4.Compound Annual Growth Rate (CAGR)

11.2.2.5.Regional Bifurcation
11.2.2.5.1.North America
11.2.2.5.1.1.Market Estimation, 2016 – 2023

11.2.2.5.1.2.Market Forecast, 2024 – 2034

11.2.2.5.2.Europe
11.2.2.5.2.1.Market Estimation, 2016 – 2023

11.2.2.5.2.2.Market Forecast, 2024 – 2034

11.2.2.5.3.Asia Pacific
11.2.2.5.3.1.Market Estimation, 2016 – 2023

11.2.2.5.3.2.Market Forecast, 2024 – 2034

11.2.2.5.4.Middle East and Africa
11.2.2.5.4.1.Market Estimation, 2016 – 2023

11.2.2.5.4.2.Market Forecast, 2024 – 2034

11.2.2.5.5.Latin America
11.2.2.5.5.1.Market Estimation, 2016 – 2023

11.2.2.5.5.2.Market Forecast, 2024 – 2034

11.2.3.Non-Profit Organization
11.2.3.1.Definition

11.2.3.2.Market Estimation and Penetration, 2016 – 2023

11.2.3.3.Market Forecast, 2024 – 2034

11.2.3.4.Compound Annual Growth Rate (CAGR)

11.2.3.5.Regional Bifurcation
11.2.3.5.1.North America
11.2.3.5.1.1.Market Estimation, 2016 – 2023

11.2.3.5.1.2.Market Forecast, 2024 – 2034

11.2.3.5.2.Europe
11.2.3.5.2.1.Market Estimation, 2016 – 2023

11.2.3.5.2.2.Market Forecast, 2024 – 2034

11.2.3.5.3.Asia Pacific
11.2.3.5.3.1.Market Estimation, 2016 – 2023

11.2.3.5.3.2.Market Forecast, 2024 – 2034

11.2.3.5.4.Middle East and Africa
11.2.3.5.4.1.Market Estimation, 2016 – 2023

11.2.3.5.4.2.Market Forecast, 2024 – 2034

11.2.3.5.5.Latin America
11.2.3.5.5.1.Market Estimation, 2016 – 2023

11.2.3.5.5.2.Market Forecast, 2024 – 2034

11.2.4.Private Organization
11.2.4.1.Definition

11.2.4.2.Market Estimation and Penetration, 2016 – 2023

11.2.4.3.Market Forecast, 2024 – 2034

11.2.4.4.Compound Annual Growth Rate (CAGR)

11.2.4.5.Regional Bifurcation
11.2.4.5.1.North America
11.2.4.5.1.1.Market Estimation, 2016 – 2023

11.2.4.5.1.2.Market Forecast, 2024 – 2034

11.2.4.5.2.Europe
11.2.4.5.2.1.Market Estimation, 2016 – 2023

11.2.4.5.2.2.Market Forecast, 2024 – 2034

11.2.4.5.3.Asia Pacific
11.2.4.5.3.1.Market Estimation, 2016 – 2023

11.2.4.5.3.2.Market Forecast, 2024 – 2034

11.2.4.5.4.Middle East and Africa
11.2.4.5.4.1.Market Estimation, 2016 – 2023

11.2.4.5.4.2.Market Forecast, 2024 – 2034

11.2.4.5.5.Latin America
11.2.4.5.5.1.Market Estimation, 2016 – 2023

11.2.4.5.5.2.Market Forecast, 2024 – 2034

11.3.Key Segment for Channeling Investments
11.3.1.By Ownership

12.Global Biobanks Market Analysis and Forecasts, 2024 – 2034
12.1.Overview

12.2.Global Biobanks Market Revenue (US$ Mn) and Forecasts, By Application
12.2.1.Regenerative Medicine
12.2.1.1.Definition

12.2.1.2.Market Estimation and Penetration, 2016 – 2023

12.2.1.3.Market Forecast, 2024 – 2034

12.2.1.4.Compound Annual Growth Rate (CAGR)

12.2.1.5.Regional Bifurcation
12.2.1.5.1.North America
12.2.1.5.1.1.Market Estimation, 2016 – 2023

12.2.1.5.1.2.Market Forecast, 2024 – 2034

12.2.1.5.2.Europe
12.2.1.5.2.1.Market Estimation, 2016 – 2023

12.2.1.5.2.2.Market Forecast, 2024 – 2034

12.2.1.5.3.Asia Pacific
12.2.1.5.3.1.Market Estimation, 2016 – 2023

12.2.1.5.3.2.Market Forecast, 2024 – 2034

12.2.1.5.4.Middle East and Africa
12.2.1.5.4.1.Market Estimation, 2016 – 2023

12.2.1.5.4.2.Market Forecast, 2024 – 2034

12.2.1.5.5.Latin America
12.2.1.5.5.1.Market Estimation, 2016 – 2023

12.2.1.5.5.2.Market Forecast, 2024 – 2034

12.2.2.Life Science Research
12.2.2.1.Definition

12.2.2.2.Market Estimation and Penetration, 2016 – 2023

12.2.2.3.Market Forecast, 2024 – 2034

12.2.2.4.Compound Annual Growth Rate (CAGR)

12.2.2.5.Regional Bifurcation
12.2.2.5.1.North America
12.2.2.5.1.1.Market Estimation, 2016 – 2023

12.2.2.5.1.2.Market Forecast, 2024 – 2034

12.2.2.5.2.Europe
12.2.2.5.2.1.Market Estimation, 2016 – 2023

12.2.2.5.2.2.Market Forecast, 2024 – 2034

12.2.2.5.3.Asia Pacific
12.2.2.5.3.1.Market Estimation, 2016 – 2023

12.2.2.5.3.2.Market Forecast, 2024 – 2034

12.2.2.5.4.Middle East and Africa
12.2.2.5.4.1.Market Estimation, 2016 – 2023

12.2.2.5.4.2.Market Forecast, 2024 – 2034

12.2.2.5.5.Latin America
12.2.2.5.5.1.Market Estimation, 2016 – 2023

12.2.2.5.5.2.Market Forecast, 2024 – 2034

12.2.3.Clinical Research
12.2.3.1.Definition

12.2.3.2.Market Estimation and Penetration, 2016 – 2023

12.2.3.3.Market Forecast, 2024 – 2034

12.2.3.4.Compound Annual Growth Rate (CAGR)

12.2.3.5.Regional Bifurcation
12.2.3.5.1.North America
12.2.3.5.1.1.Market Estimation, 2016 – 2023

12.2.3.5.1.2.Market Forecast, 2024 – 2034

12.2.3.5.2.Europe
12.2.3.5.2.1.Market Estimation, 2016 – 2023

12.2.3.5.2.2.Market Forecast, 2024 – 2034

12.2.3.5.3.Asia Pacific
12.2.3.5.3.1.Market Estimation, 2016 – 2023

12.2.3.5.3.2.Market Forecast, 2024 – 2034

12.2.3.5.4.Middle East and Africa
12.2.3.5.4.1.Market Estimation, 2016 – 2023

12.2.3.5.4.2.Market Forecast, 2024 – 2034

12.2.3.5.5.Latin America
12.2.3.5.5.1.Market Estimation, 2016 – 2023

12.2.3.5.5.2.Market Forecast, 2024 – 2034

12.3.Key Segment for Channeling Investments
12.3.1.By Application

13.Global Biobanks Market Analysis and Forecasts, 2024 – 2034
13.1.Overview

13.2.Global Biobanks Market Revenue (US$ Mn) and Forecasts, By End-User
13.2.1.Pharmaceutical and Biotechnology Companies and CROs
13.2.1.1.Definition

13.2.1.2.Market Estimation and Penetration, 2016 – 2023

13.2.1.3.Market Forecast, 2024 – 2034

13.2.1.4.Compound Annual Growth Rate (CAGR)

13.2.1.5.Regional Bifurcation
13.2.1.5.1.North America
13.2.1.5.1.1.Market Estimation, 2016 – 2023

13.2.1.5.1.2.Market Forecast, 2024 – 2034

13.2.1.5.2.Europe
13.2.1.5.2.1.Market Estimation, 2016 – 2023

13.2.1.5.2.2.Market Forecast, 2024 – 2034

13.2.1.5.3.Asia Pacific
13.2.1.5.3.1.Market Estimation, 2016 – 2023

13.2.1.5.3.2.Market Forecast, 2024 – 2034

13.2.1.5.4.Middle East and Africa
13.2.1.5.4.1.Market Estimation, 2016 – 2023

13.2.1.5.4.2.Market Forecast, 2024 – 2034

13.2.1.5.5.Latin America
13.2.1.5.5.1.Market Estimation, 2016 – 2023

13.2.1.5.5.2.Market Forecast, 2024 – 2034

13.2.2.Academic and Research Institutes
13.2.2.1.Definition

13.2.2.2.Market Estimation and Penetration, 2016 – 2023

13.2.2.3.Market Forecast, 2024 – 2034

13.2.2.4.Compound Annual Growth Rate (CAGR)

13.2.2.5.Regional Bifurcation
13.2.2.5.1.North America
13.2.2.5.1.1.Market Estimation, 2016 – 2023

13.2.2.5.1.2.Market Forecast, 2024 – 2034

13.2.2.5.2.Europe
13.2.2.5.2.1.Market Estimation, 2016 – 2023

13.2.2.5.2.2.Market Forecast, 2024 – 2034

13.2.2.5.3.Asia Pacific
13.2.2.5.3.1.Market Estimation, 2016 – 2023

13.2.2.5.3.2.Market Forecast, 2024 – 2034

13.2.2.5.4.Middle East and Africa
13.2.2.5.4.1.Market Estimation, 2016 – 2023

13.2.2.5.4.2.Market Forecast, 2024 – 2034

13.2.2.5.5.Latin America
13.2.2.5.5.1.Market Estimation, 2016 – 2023

13.2.2.5.5.2.Market Forecast, 2024 – 2034

13.2.3.Hospitals
13.2.3.1.Definition

13.2.3.2.Market Estimation and Penetration, 2016 – 2023

13.2.3.3.Market Forecast, 2024 – 2034

13.2.3.4.Compound Annual Growth Rate (CAGR)

13.2.3.5.Regional Bifurcation
13.2.3.5.1.North America
13.2.3.5.1.1.Market Estimation, 2016 – 2023

13.2.3.5.1.2.Market Forecast, 2024 – 2034

13.2.3.5.2.Europe
13.2.3.5.2.1.Market Estimation, 2016 – 2023

13.2.3.5.2.2.Market Forecast, 2024 – 2034

13.2.3.5.3.Asia Pacific
13.2.3.5.3.1.Market Estimation, 2016 – 2023

13.2.3.5.3.2.Market Forecast, 2024 – 2034

13.2.3.5.4.Middle East and Africa
13.2.3.5.4.1.Market Estimation, 2016 – 2023

13.2.3.5.4.2.Market Forecast, 2024 – 2034

13.2.3.5.5.Latin America
13.2.3.5.5.1.Market Estimation, 2016 – 2023

13.2.3.5.5.2.Market Forecast, 2024 – 2034

13.3.Key Segment for Channeling Investments
13.3.1.By End-User

14.North America Biobanks Market Analysis and Forecasts, 2024 – 2034
14.1.Overview
14.1.1.North America Biobanks Market Revenue (US$ Mn)

14.2.North America Biobanks Market Revenue (US$ Mn) and Forecasts, By Product and Services
14.2.1.Equipment
14.2.1.1.Storage Equipment

14.2.1.2.Sample Analysis Equipment

14.2.1.3.Sample Processing Equipment

14.2.1.4.Sample Transport Equipment

14.2.2.Consumables
14.2.2.1.Storage Consumables

14.2.2.2.Analysis Consumables

14.2.2.3.Processing Consumables

14.2.2.4.Collection Consumables

14.2.3.Services
14.2.3.1.Storage Services

14.2.3.2.Processing Services

14.2.3.3.Transport Services

14.2.3.4.Supply Services

14.2.4.Software

14.3.North America Biobanks Market Revenue (US$ Mn) and Forecasts, By Sample Type
14.3.1.Blood Products

14.3.2.Human Tissues

14.3.3.Cell Lines

14.3.4.Nucleic Acids

14.3.5.Biological Fluids

14.3.6.Human Waste Product

14.4.North America Biobanks Market Revenue (US$ Mn) and Forecasts, By Storage Type
14.4.1.Manual Storage

14.4.2.Automated Storage

14.5.North America Biobanks Market Revenue (US$ Mn) and Forecasts, By Ownership
14.5.1.Universities

14.5.2.National/ Regional Agencies

14.5.3.Non-Profit Organization

14.5.4.Private Organization

14.6.North America Biobanks Market Revenue (US$ Mn) and Forecasts, By Application
14.6.1.Regenerative Medicine

14.6.2.Life Science Research

14.6.3.Clinical Research

14.7.North America Biobanks Market Revenue (US$ Mn) and Forecasts, By End-User
14.7.1.Pharmaceutical and Biotechnology Companies and CROs

14.7.2.Academic and Research Institutes

14.7.3.Hospitals

14.8.North America Biobanks Market Revenue (US$ Mn) and Forecasts, By Country
14.8.1.U.S
14.8.1.1.U.S Biobanks Market Revenue (US$ Mn) and Forecasts, By Product and Services
14.8.1.1.1.Equipment
14.8.1.1.1.1.Storage Equipment

14.8.1.1.1.2.Sample Analysis Equipment

14.8.1.1.1.3.Sample Processing Equipment

14.8.1.1.1.4.Sample Transport Equipment

14.8.1.1.2.Consumables
14.8.1.1.2.1.Storage Consumables

14.8.1.1.2.2.Analysis Consumables

14.8.1.1.2.3.Processing Consumables

14.8.1.1.2.4.Collection Consumables

14.8.1.1.3.Services
14.8.1.1.3.1.Storage Services

14.8.1.1.3.2.Processing Services

14.8.1.1.3.3.Transport Services

14.8.1.1.3.4.Supply Services

14.8.1.1.4.Software

14.8.1.2.U.S Biobanks Market Revenue (US$ Mn) and Forecasts, By Sample Type
14.8.1.2.1.Blood Products

14.8.1.2.2.Human Tissues

14.8.1.2.3.Cell Lines

14.8.1.2.4.Nucleic Acids

14.8.1.2.5.Biological Fluids

14.8.1.2.6.Human Waste Product

14.8.1.3.U.S Biobanks Market Revenue (US$ Mn) and Forecasts, By Storage Type
14.8.1.3.1.Manual Storage

14.8.1.3.2.Automated Storage

14.8.1.4.U.S Biobanks Market Revenue (US$ Mn) and Forecasts, By Ownership
14.8.1.4.1.Universities

14.8.1.4.2.National/ Regional Agencies

14.8.1.4.3.Non-Profit Organization

14.8.1.4.4.Private Organization

14.8.1.5.U.S Biobanks Market Revenue (US$ Mn) and Forecasts, By Application
14.8.1.5.1.Regenerative Medicine

14.8.1.5.2.Life Science Research

14.8.1.5.3.Clinical Research

14.8.1.6.U.S Biobanks Market Revenue (US$ Mn) and Forecasts, By End-User
14.8.1.6.1.Pharmaceutical and Biotechnology Companies and CROs

14.8.1.6.2.Academic and Research Institutes

14.8.1.6.3.Hospitals

14.8.2.Canada
14.8.2.1.Canada Biobanks Market Revenue (US$ Mn) and Forecasts, By Product and Services
14.8.2.1.1.Equipment
14.8.2.1.1.1.Storage Equipment

14.8.2.1.1.2.Sample Analysis Equipment

14.8.2.1.1.3.Sample Processing Equipment

14.8.2.1.1.4.Sample Transport Equipment

14.8.2.1.2.Consumables
14.8.2.1.2.1.Storage Consumables

14.8.2.1.2.2.Analysis Consumables

14.8.2.1.2.3.Processing Consumables

14.8.2.1.2.4.Collection Consumables

14.8.2.1.3.Services
14.8.2.1.3.1.Storage Services

14.8.2.1.3.2.Processing Services

14.8.2.1.3.3.Transport Services

14.8.2.1.3.4.Supply Services

14.8.2.1.4.Software

14.8.2.2.Canada Biobanks Market Revenue (US$ Mn) and Forecasts, By Sample Type
14.8.2.2.1.Blood Products

14.8.2.2.2.Human Tissues

14.8.2.2.3.Cell Lines

14.8.2.2.4.Nucleic Acids

14.8.2.2.5.Biological Fluids

14.8.2.2.6.Human Waste Product

14.8.2.3.Canada Biobanks Market Revenue (US$ Mn) and Forecasts, By Storage Type
14.8.2.3.1.Manual Storage

14.8.2.3.2.Automated Storage

14.8.2.4.Canada Biobanks Market Revenue (US$ Mn) and Forecasts, By Ownership
14.8.2.4.1.Universities

14.8.2.4.2.National/ Regional Agencies

14.8.2.4.3.Non-Profit Organization

14.8.2.4.4.Private Organization

14.8.2.5.Canada Biobanks Market Revenue (US$ Mn) and Forecasts, By Application
14.8.2.5.1.Regenerative Medicine

14.8.2.5.2.Life Science Research

14.8.2.5.3.Clinical Research

14.8.2.6.Canada Biobanks Market Revenue (US$ Mn) and Forecasts, By End-User
14.8.2.6.1.Pharmaceutical and Biotechnology Companies and CROs

14.8.2.6.2.Academic and Research Institutes

14.8.2.6.3.Hospitals

14.8.3.Mexico
14.8.3.1.Mexico Biobanks Market Revenue (US$ Mn) and Forecasts, By Product and Services
14.8.3.1.1.Equipment
14.8.3.1.1.1.Storage Equipment

14.8.3.1.1.2.Sample Analysis Equipment

14.8.3.1.1.3.Sample Processing Equipment

14.8.3.1.1.4.Sample Transport Equipment

14.8.3.1.2.Consumables
14.8.3.1.2.1.Storage Consumables

14.8.3.1.2.2.Analysis Consumables

14.8.3.1.2.3.Processing Consumables

14.8.3.1.2.4.Collection Consumables

14.8.3.1.3.Services
14.8.3.1.3.1.Storage Services

14.8.3.1.3.2.Processing Services

14.8.3.1.3.3.Transport Services

14.8.3.1.3.4.Supply Services

14.8.3.1.4.Software

14.8.3.2.Mexico Biobanks Market Revenue (US$ Mn) and Forecasts, By Sample Type
14.8.3.2.1.Blood Products

14.8.3.2.2.Human Tissues

14.8.3.2.3.Cell Lines

14.8.3.2.4.Nucleic Acids

14.8.3.2.5.Biological Fluids

14.8.3.2.6.Human Waste Product

14.8.3.3.Mexico Biobanks Market Revenue (US$ Mn) and Forecasts, By Storage Type
14.8.3.3.1.Manual Storage

14.8.3.3.2.Automated Storage

14.8.3.4.Mexico Biobanks Market Revenue (US$ Mn) and Forecasts, By Ownership
14.8.3.4.1.Universities

14.8.3.4.2.National/ Regional Agencies

14.8.3.4.3.Non-Profit Organization

14.8.3.4.4.Private Organization

14.8.3.5.Mexico Biobanks Market Revenue (US$ Mn) and Forecasts, By Application
14.8.3.5.1.Regenerative Medicine

14.8.3.5.2.Life Science Research

14.8.3.5.3.Clinical Research

14.8.3.6.Mexico Biobanks Market Revenue (US$ Mn) and Forecasts, By End-User
14.8.3.6.1.Pharmaceutical and Biotechnology Companies and CROs

14.8.3.6.2.Academic and Research Institutes

14.8.3.6.3.Hospitals

14.8.4.Rest of North America
14.8.4.1.Rest of North America Biobanks Market Revenue (US$ Mn) and Forecasts, By Product and Services
14.8.4.1.1.Equipment
14.8.4.1.1.1.Storage Equipment

14.8.4.1.1.2.Sample Analysis Equipment

14.8.4.1.1.3.Sample Processing Equipment

14.8.4.1.1.4.Sample Transport Equipment

14.8.4.1.2.Consumables
14.8.4.1.2.1.Storage Consumables

14.8.4.1.2.2.Analysis Consumables

14.8.4.1.2.3.Processing Consumables

14.8.4.1.2.4.Collection Consumables

14.8.4.1.3.Services
14.8.4.1.3.1.Storage Services

14.8.4.1.3.2.Processing Services

14.8.4.1.3.3.Transport Services

14.8.4.1.3.4.Supply Services

14.8.4.1.4.Software

14.8.4.2.Rest of North America Biobanks Market Revenue (US$ Mn) and Forecasts, By Sample Type
14.8.4.2.1.Blood Products

14.8.4.2.2.Human Tissues

14.8.4.2.3.Cell Lines

14.8.4.2.4.Nucleic Acids

14.8.4.2.5.Biological Fluids

14.8.4.2.6.Human Waste Product

14.8.4.3.Rest of North America Biobanks Market Revenue (US$ Mn) and Forecasts, By Storage Type
14.8.4.3.1.Manual Storage

14.8.4.3.2.Automated Storage

14.8.4.4.Rest of North America Biobanks Market Revenue (US$ Mn) and Forecasts, By Ownership
14.8.4.4.1.Universities

14.8.4.4.2.National/ Regional Agencies

14.8.4.4.3.Non-Profit Organization

14.8.4.4.4.Private Organization

14.8.4.5.Rest of North America Biobanks Market Revenue (US$ Mn) and Forecasts, By Application
14.8.4.5.1.Regenerative Medicine

14.8.4.5.2.Life Science Research

14.8.4.5.3.Clinical Research

14.8.4.6.Rest of North America Biobanks Market Revenue (US$ Mn) and Forecasts, By End-User
14.8.4.6.1.Pharmaceutical and Biotechnology Companies and CROs

14.8.4.6.2.Academic and Research Institutes

14.8.4.6.3.Hospitals

14.9.Key Segment for Channeling Investments
14.9.1.By Country

14.9.2.By Product and Services

14.9.3.By Sample Type

14.9.4.By Storage Type

14.9.5.By Ownership

14.9.6.By Application

14.9.7.By End-User

15.Europe Biobanks Market Analysis and Forecasts, 2024 – 2034
15.1.Overview
15.1.1.Europe Biobanks Market Revenue (US$ Mn)

15.2.Europe Biobanks Market Revenue (US$ Mn) and Forecasts, By Product and Services
15.2.1.Equipment
15.2.1.1.Storage Equipment

15.2.1.2.Sample Analysis Equipment

15.2.1.3.Sample Processing Equipment

15.2.1.4.Sample Transport Equipment

15.2.2.Consumables
15.2.2.1.Storage Consumables

15.2.2.2.Analysis Consumables

15.2.2.3.Processing Consumables

15.2.2.4.Collection Consumables

15.2.3.Services
15.2.3.1.Storage Services

15.2.3.2.Processing Services

15.2.3.3.Transport Services

15.2.3.4.Supply Services

15.2.4.Software

15.3.Europe Biobanks Market Revenue (US$ Mn) and Forecasts, By Sample Type
15.3.1.Blood Products

15.3.2.Human Tissues

15.3.3.Cell Lines

15.3.4.Nucleic Acids

15.3.5.Biological Fluids

15.3.6.Human Waste Product

15.4.Europe Biobanks Market Revenue (US$ Mn) and Forecasts, By Storage Type
15.4.1.Manual Storage

15.4.2.Automated Storage

15.5.Europe Biobanks Market Revenue (US$ Mn) and Forecasts, By Ownership
15.5.1.Universities

15.5.2.National/ Regional Agencies

15.5.3.Non-Profit Organization

15.5.4.Private Organization

15.6.Europe Biobanks Market Revenue (US$ Mn) and Forecasts, By Application
15.6.1.Regenerative Medicine

15.6.2.Life Science Research

15.6.3.Clinical Research

15.7.Europe Biobanks Market Revenue (US$ Mn) and Forecasts, By End-User
15.7.1.Pharmaceutical and Biotechnology Companies and CROs

15.7.2.Academic and Research Institutes

15.7.3.Hospitals

15.8.Europe Biobanks Market Revenue (US$ Mn) and Forecasts, By Country
15.8.1.France
15.8.1.1.France Biobanks Market Revenue (US$ Mn) and Forecasts, By Product and Services
15.8.1.1.1.Equipment
15.8.1.1.1.1.Storage Equipment

15.8.1.1.1.2.Sample Analysis Equipment

15.8.1.1.1.3.Sample Processing Equipment

15.8.1.1.1.4.Sample Transport Equipment

15.8.1.1.2.Consumables
15.8.1.1.2.1.Storage Consumables

15.8.1.1.2.2.Analysis Consumables

15.8.1.1.2.3.Processing Consumables

15.8.1.1.2.4.Collection Consumables

15.8.1.1.3.Services
15.8.1.1.3.1.Storage Services

15.8.1.1.3.2.Processing Services

15.8.1.1.3.3.Transport Services

15.8.1.1.3.4.Supply Services

15.8.1.1.4.Software

15.8.1.2.France Biobanks Market Revenue (US$ Mn) and Forecasts, By Sample Type
15.8.1.2.1.Blood Products

15.8.1.2.2.Human Tissues

15.8.1.2.3.Cell Lines

15.8.1.2.4.Nucleic Acids

15.8.1.2.5.Biological Fluids

15.8.1.2.6.Human Waste Product

15.8.1.3.France Biobanks Market Revenue (US$ Mn) and Forecasts, By Storage Type
15.8.1.3.1.Manual Storage

15.8.1.3.2.Automated Storage

15.8.1.4.France Biobanks Market Revenue (US$ Mn) and Forecasts, By Ownership
15.8.1.4.1.Universities

15.8.1.4.2.National/ Regional Agencies

15.8.1.4.3.Non-Profit Organization

15.8.1.4.4.Private Organization

15.8.1.5.France Biobanks Market Revenue (US$ Mn) and Forecasts, By Application
15.8.1.5.1.Regenerative Medicine

15.8.1.5.2.Life Science Research

15.8.1.5.3.Clinical Research

15.8.1.6.France Biobanks Market Revenue (US$ Mn) and Forecasts, By End-User
15.8.1.6.1.Pharmaceutical and Biotechnology Companies and CROs

15.8.1.6.2.Academic and Research Institutes

15.8.1.6.3.Hospitals

15.8.2.The UK
15.8.2.1.The UK Biobanks Market Revenue (US$ Mn) and Forecasts, By Product and Services
15.8.2.1.1.Equipment
15.8.2.1.1.1.Storage Equipment

15.8.2.1.1.2.Sample Analysis Equipment

15.8.2.1.1.3.Sample Processing Equipment

15.8.2.1.1.4.Sample Transport Equipment

15.8.2.1.2.Consumables
15.8.2.1.2.1.Storage Consumables

15.8.2.1.2.2.Analysis Consumables

15.8.2.1.2.3.Processing Consumables

15.8.2.1.2.4.Collection Consumables

15.8.2.1.3.Services
15.8.2.1.3.1.Storage Services

15.8.2.1.3.2.Processing Services

15.8.2.1.3.3.Transport Services

15.8.2.1.3.4.Supply Services

15.8.2.1.4.Software

15.8.2.2.The UK Biobanks Market Revenue (US$ Mn) and Forecasts, By Sample Type
15.8.2.2.1.Blood Products

15.8.2.2.2.Human Tissues

15.8.2.2.3.Cell Lines

15.8.2.2.4.Nucleic Acids

15.8.2.2.5.Biological Fluids

15.8.2.2.6.Human Waste Product

15.8.2.3.The UK Biobanks Market Revenue (US$ Mn) and Forecasts, By Storage Type
15.8.2.3.1.Manual Storage

15.8.2.3.2.Automated Storage

15.8.2.4.The UK Biobanks Market Revenue (US$ Mn) and Forecasts, By Ownership
15.8.2.4.1.Universities

15.8.2.4.2.National/ Regional Agencies

15.8.2.4.3.Non-Profit Organization

15.8.2.4.4.Private Organization

15.8.2.5.The UK Biobanks Market Revenue (US$ Mn) and Forecasts, By Application
15.8.2.5.1.Regenerative Medicine

15.8.2.5.2.Life Science Research

15.8.2.5.3.Clinical Research

15.8.2.6.The UK Biobanks Market Revenue (US$ Mn) and Forecasts, By End-User
15.8.2.6.1.Pharmaceutical and Biotechnology Companies and CROs

15.8.2.6.2.Academic and Research Institutes

15.8.2.6.3.Hospitals

15.8.3.Spain
15.8.3.1.Spain Biobanks Market Revenue (US$ Mn) and Forecasts, By Product and Services
15.8.3.1.1.Equipment
15.8.3.1.1.1.Storage Equipment

15.8.3.1.1.2.Sample Analysis Equipment

15.8.3.1.1.3.Sample Processing Equipment

15.8.3.1.1.4.Sample Transport Equipment

15.8.3.1.2.Consumables
15.8.3.1.2.1.Storage Consumables

15.8.3.1.2.2.Analysis Consumables

15.8.3.1.2.3.Processing Consumables

15.8.3.1.2.4.Collection Consumables

15.8.3.1.3.Services
15.8.3.1.3.1.Storage Services

15.8.3.1.3.2.Processing Services

15.8.3.1.3.3.Transport Services

15.8.3.1.3.4.Supply Services

15.8.3.1.4.Software

15.8.3.2.Spain Biobanks Market Revenue (US$ Mn) and Forecasts, By Sample Type
15.8.3.2.1.Blood Products

15.8.3.2.2.Human Tissues

15.8.3.2.3.Cell Lines

15.8.3.2.4.Nucleic Acids

15.8.3.2.5.Biological Fluids

15.8.3.2.6.Human Waste Product

15.8.3.3.Spain Biobanks Market Revenue (US$ Mn) and Forecasts, By Storage Type
15.8.3.3.1.Manual Storage

15.8.3.3.2.Automated Storage

15.8.3.4.Spain Biobanks Market Revenue (US$ Mn) and Forecasts, By Ownership
15.8.3.4.1.Universities

15.8.3.4.2.National/ Regional Agencies

15.8.3.4.3.Non-Profit Organization

15.8.3.4.4.Private Organization

15.8.3.5.Spain Biobanks Market Revenue (US$ Mn) and Forecasts, By Application
15.8.3.5.1.Regenerative Medicine

15.8.3.5.2.Life Science Research

15.8.3.5.3.Clinical Research

15.8.3.6.Spain Biobanks Market Revenue (US$ Mn) and Forecasts, By End-User
15.8.3.6.1.Pharmaceutical and Biotechnology Companies and CROs

15.8.3.6.2.Academic and Research Institutes

15.8.3.6.3.Hospitals

15.8.4.Germany
15.8.4.1.Germany Biobanks Market Revenue (US$ Mn) and Forecasts, By Product and Services
15.8.4.1.1.Equipment
15.8.4.1.1.1.Storage Equipment

15.8.4.1.1.2.Sample Analysis Equipment

15.8.4.1.1.3.Sample Processing Equipment

15.8.4.1.1.4.Sample Transport Equipment

15.8.4.1.2.Consumables
15.8.4.1.2.1.Storage Consumables

15.8.4.1.2.2.Analysis Consumables

15.8.4.1.2.3.Processing Consumables

15.8.4.1.2.4.Collection Consumables

15.8.4.1.3.Services
15.8.4.1.3.1.Storage Services

15.8.4.1.3.2.Processing Services

15.8.4.1.3.3.Transport Services

15.8.4.1.3.4.Supply Services

15.8.4.1.4.Software

15.8.4.2.Germany Biobanks Market Revenue (US$ Mn) and Forecasts, By Sample Type
15.8.4.2.1.Blood Products

15.8.4.2.2.Human Tissues

15.8.4.2.3.Cell Lines

15.8.4.2.4.Nucleic Acids

15.8.4.2.5.Biological Fluids

15.8.4.2.6.Human Waste Product

15.8.4.3.Germany Biobanks Market Revenue (US$ Mn) and Forecasts, By Storage Type
15.8.4.3.1.Manual Storage

15.8.4.3.2.Automated Storage

15.8.4.4.Germany Biobanks Market Revenue (US$ Mn) and Forecasts, By Ownership
15.8.4.4.1.Universities

15.8.4.4.2.National/ Regional Agencies

15.8.4.4.3.Non-Profit Organization

15.8.4.4.4.Private Organization

15.8.4.5.Germany Biobanks Market Revenue (US$ Mn) and Forecasts, By Application
15.8.4.5.1.Regenerative Medicine

15.8.4.5.2.Life Science Research

15.8.4.5.3.Clinical Research

15.8.4.6.Germany Biobanks Market Revenue (US$ Mn) and Forecasts, By End-User
15.8.4.6.1.Pharmaceutical and Biotechnology Companies and CROs

15.8.4.6.2.Academic and Research Institutes

15.8.4.6.3.Hospitals

15.8.5.Italy
15.8.5.1.Italy Biobanks Market Revenue (US$ Mn) and Forecasts, By Product and Services
15.8.5.1.1.Equipment
15.8.5.1.1.1.Storage Equipment

15.8.5.1.1.2.Sample Analysis Equipment

15.8.5.1.1.3.Sample Processing Equipment

15.8.5.1.1.4.Sample Transport Equipment

15.8.5.1.2.Consumables
15.8.5.1.2.1.Storage Consumables

15.8.5.1.2.2.Analysis Consumables

15.8.5.1.2.3.Processing Consumables

15.8.5.1.2.4.Collection Consumables

15.8.5.1.3.Services
15.8.5.1.3.1.Storage Services

15.8.5.1.3.2.Processing Services

15.8.5.1.3.3.Transport Services

15.8.5.1.3.4.Supply Services

15.8.5.1.4.Software

15.8.5.2.Italy Biobanks Market Revenue (US$ Mn) and Forecasts, By Sample Type
15.8.5.2.1.Blood Products

15.8.5.2.2.Human Tissues

15.8.5.2.3.Cell Lines

15.8.5.2.4.Nucleic Acids

15.8.5.2.5.Biological Fluids

15.8.5.2.6.Human Waste Product

15.8.5.3.Italy Biobanks Market Revenue (US$ Mn) and Forecasts, By Storage Type
15.8.5.3.1.Manual Storage

15.8.5.3.2.Automated Storage

15.8.5.4.Italy Biobanks Market Revenue (US$ Mn) and Forecasts, By Ownership
15.8.5.4.1.Universities

15.8.5.4.2.National/ Regional Agencies

15.8.5.4.3.Non-Profit Organization

15.8.5.4.4.Private Organization

15.8.5.5.Italy Biobanks Market Revenue (US$ Mn) and Forecasts, By Application
15.8.5.5.1.Regenerative Medicine

15.8.5.5.2.Life Science Research

15.8.5.5.3.Clinical Research

15.8.5.6.Italy Biobanks Market Revenue (US$ Mn) and Forecasts, By End-User
15.8.5.6.1.Pharmaceutical and Biotechnology Companies and CROs

15.8.5.6.2.Academic and Research Institutes

15.8.5.6.3.Hospitals

15.8.6.Nordic Countries
15.8.6.1.Nordic Countries Biobanks Market Revenue (US$ Mn) and Forecasts, By Product and Services
15.8.6.1.1.Equipment
15.8.6.1.1.1.Storage Equipment

15.8.6.1.1.2.Sample Analysis Equipment

15.8.6.1.1.3.Sample Processing Equipment

15.8.6.1.1.4.Sample Transport Equipment

15.8.6.1.2.Consumables
15.8.6.1.2.1.Storage Consumables

15.8.6.1.2.2.Analysis Consumables

15.8.6.1.2.3.Processing Consumables

15.8.6.1.2.4.Collection Consumables

15.8.6.1.3.Services
15.8.6.1.3.1.Storage Services

15.8.6.1.3.2.Processing Services

15.8.6.1.3.3.Transport Services

15.8.6.1.3.4.Supply Services

15.8.6.1.4.Software

15.8.6.2.Nordic Countries Biobanks Market Revenue (US$ Mn) and Forecasts, By Sample Type
15.8.6.2.1.Blood Products

15.8.6.2.2.Human Tissues

15.8.6.2.3.Cell Lines

15.8.6.2.4.Nucleic Acids

15.8.6.2.5.Biological Fluids

15.8.6.2.6.Human Waste Product

15.8.6.3.Nordic Countries Biobanks Market Revenue (US$ Mn) and Forecasts, By Storage Type
15.8.6.3.1.Manual Storage

15.8.6.3.2.Automated Storage

15.8.6.4.Nordic Countries Biobanks Market Revenue (US$ Mn) and Forecasts, By Ownership
15.8.6.4.1.Universities

15.8.6.4.2.National/ Regional Agencies

15.8.6.4.3.Non-Profit Organization

15.8.6.4.4.Private Organization

15.8.6.5.Nordic Countries Biobanks Market Revenue (US$ Mn) and Forecasts, By Application
15.8.6.5.1.Regenerative Medicine

15.8.6.5.2.Life Science Research

15.8.6.5.3.Clinical Research

15.8.6.6.Nordic Countries Biobanks Market Revenue (US$ Mn) and Forecasts, By End-User
15.8.6.6.1.Pharmaceutical and Biotechnology Companies and CROs

15.8.6.6.2.Academic and Research Institutes

15.8.6.6.3.Hospitals

15.8.6.7.Nordic Countries Biobanks Market Revenue (US$ Mn) and Forecasts, By Country
15.8.6.7.1.Denmark

15.8.6.7.2.Finland

15.8.6.7.3.Iceland

15.8.6.7.4.Sweden

15.8.6.7.5.Norway

15.8.7.Benelux Union
15.8.7.1.Benelux Union Biobanks Market Revenue (US$ Mn) and Forecasts, By Product and Services
15.8.7.1.1.Equipment
15.8.7.1.1.1.Storage Equipment

15.8.7.1.1.2.Sample Analysis Equipment

15.8.7.1.1.3.Sample Processing Equipment

15.8.7.1.1.4.Sample Transport Equipment

15.8.7.1.2.Consumables
15.8.7.1.2.1.Storage Consumables

15.8.7.1.2.2.Analysis Consumables

15.8.7.1.2.3.Processing Consumables

15.8.7.1.2.4.Collection Consumables

15.8.7.1.3.Services
15.8.7.1.3.1.Storage Services

15.8.7.1.3.2.Processing Services

15.8.7.1.3.3.Transport Services

15.8.7.1.3.4.Supply Services

15.8.7.1.4.Software

15.8.7.2.Benelux Union Biobanks Market Revenue (US$ Mn) and Forecasts, By Sample Type
15.8.7.2.1.Blood Products

15.8.7.2.2.Human Tissues

15.8.7.2.3.Cell Lines

15.8.7.2.4.Nucleic Acids

15.8.7.2.5.Biological Fluids

15.8.7.2.6.Human Waste Product

15.8.7.3.Benelux Union Biobanks Market Revenue (US$ Mn) and Forecasts, By Storage Type
15.8.7.3.1.Manual Storage

15.8.7.3.2.Automated Storage

15.8.7.4.Benelux Union Biobanks Market Revenue (US$ Mn) and Forecasts, By Ownership
15.8.7.4.1.Universities

15.8.7.4.2.National/ Regional Agencies

15.8.7.4.3.Non-Profit Organization

15.8.7.4.4.Private Organization

15.8.7.5.Benelux Union Biobanks Market Revenue (US$ Mn) and Forecasts, By Application
15.8.7.5.1.Regenerative Medicine

15.8.7.5.2.Life Science Research

15.8.7.5.3.Clinical Research

15.8.7.6.Benelux Union Biobanks Market Revenue (US$ Mn) and Forecasts, By End-User
15.8.7.6.1.Pharmaceutical and Biotechnology Companies and CROs

15.8.7.6.2.Academic and Research Institutes

15.8.7.6.3.Hospitals

15.8.7.7.Benelux Union Biobanks Market Revenue (US$ Mn) and Forecasts, By Country
15.8.7.7.1.Belgium

15.8.7.7.2.The Netherlands

15.8.7.7.3.Luxembourg

15.8.8.Rest of Europe
15.8.8.1.Rest of Europe Biobanks Market Revenue (US$ Mn) and Forecasts, By Product and Services
15.8.8.1.1.Equipment
15.8.8.1.1.1.Storage Equipment

15.8.8.1.1.2.Sample Analysis Equipment

15.8.8.1.1.3.Sample Processing Equipment

15.8.8.1.1.4.Sample Transport Equipment

15.8.8.1.2.Consumables
15.8.8.1.2.1.Storage Consumables

15.8.8.1.2.2.Analysis Consumables

15.8.8.1.2.3.Processing Consumables

15.8.8.1.2.4.Collection Consumables

15.8.8.1.3.Services
15.8.8.1.3.1.Storage Services

15.8.8.1.3.2.Processing Services

15.8.8.1.3.3.Transport Services

15.8.8.1.3.4.Supply Services

15.8.8.1.4.Software

15.8.8.2.Rest of Europe Biobanks Market Revenue (US$ Mn) and Forecasts, By Sample Type
15.8.8.2.1.Blood Products

15.8.8.2.2.Human Tissues

15.8.8.2.3.Cell Lines

15.8.8.2.4.Nucleic Acids

15.8.8.2.5.Biological Fluids

15.8.8.2.6.Human Waste Product

15.8.8.3.Rest of Europe Biobanks Market Revenue (US$ Mn) and Forecasts, By Storage Type
15.8.8.3.1.Manual Storage

15.8.8.3.2.Automated Storage

15.8.8.4.Rest of Europe Biobanks Market Revenue (US$ Mn) and Forecasts, By Ownership
15.8.8.4.1.Universities

15.8.8.4.2.National/ Regional Agencies

15.8.8.4.3.Non-Profit Organization

15.8.8.4.4.Private Organization

15.8.8.5.Rest of Europe Biobanks Market Revenue (US$ Mn) and Forecasts, By Application
15.8.8.5.1.Regenerative Medicine

15.8.8.5.2.Life Science Research

15.8.8.5.3.Clinical Research

15.8.8.6.Rest of Europe Biobanks Market Revenue (US$ Mn) and Forecasts, By End-User
15.8.8.6.1.Pharmaceutical and Biotechnology Companies and CROs

15.8.8.6.2.Academic and Research Institutes

15.8.8.6.3.Hospitals

15.9.Key Segment for Channeling Investments
15.9.1.By Country

15.9.2.By Product and Services

15.9.3.By Sample Type

15.9.4.By Storage Type

15.9.5.By Ownership

15.9.6.By Application

15.9.7.By End-User

16.Asia Pacific Biobanks Market Analysis and Forecasts, 2024 – 2034
16.1.Overview
16.1.1.Asia Pacific Biobanks Market Revenue (US$ Mn)

16.2.Asia Pacific Biobanks Market Revenue (US$ Mn) and Forecasts, By Product and Services
16.2.1.Equipment
16.2.1.1.Storage Equipment

16.2.1.2.Sample Analysis Equipment

16.2.1.3.Sample Processing Equipment

16.2.1.4.Sample Transport Equipment

16.2.2.Consumables
16.2.2.1.Storage Consumables

16.2.2.2.Analysis Consumables

16.2.2.3.Processing Consumables

16.2.2.4.Collection Consumables

16.2.3.Services
16.2.3.1.Storage Services

16.2.3.2.Processing Services

16.2.3.3.Transport Services

16.2.3.4.Supply Services

16.2.4.Software

16.3.Asia Pacific Biobanks Market Revenue (US$ Mn) and Forecasts, By Sample Type
16.3.1.Blood Products

16.3.2.Human Tissues

16.3.3.Cell Lines

16.3.4.Nucleic Acids

16.3.5.Biological Fluids

16.3.6.Human Waste Product

16.4.Asia Pacific Biobanks Market Revenue (US$ Mn) and Forecasts, By Storage Type
16.4.1.Manual Storage

16.4.2.Automated Storage

16.5.Asia Pacific Biobanks Market Revenue (US$ Mn) and Forecasts, By Ownership
16.5.1.Universities

16.5.2.National/ Regional Agencies

16.5.3.Non-Profit Organization

16.5.4.Private Organization

16.6.Asia Pacific Biobanks Market Revenue (US$ Mn) and Forecasts, By Application
16.6.1.Regenerative Medicine

16.6.2.Life Science Research

16.6.3.Clinical Research

16.7.Asia Pacific Biobanks Market Revenue (US$ Mn) and Forecasts, By End-User
16.7.1.Pharmaceutical and Biotechnology Companies and CROs

16.7.2.Academic and Research Institutes

16.7.3.Hospitals

16.8.Asia Pacific Biobanks Market Revenue (US$ Mn) and Forecasts, By Country
16.8.1.China
16.8.1.1.China Biobanks Market Revenue (US$ Mn) and Forecasts, By Product and Services
16.8.1.1.1.Equipment
16.8.1.1.1.1.Storage Equipment

16.8.1.1.1.2.Sample Analysis Equipment

16.8.1.1.1.3.Sample Processing Equipment

16.8.1.1.1.4.Sample Transport Equipment

16.8.1.1.2.Consumables
16.8.1.1.2.1.Storage Consumables

16.8.1.1.2.2.Analysis Consumables

16.8.1.1.2.3.Processing Consumables

16.8.1.1.2.4.Collection Consumables

16.8.1.1.3.Services
16.8.1.1.3.1.Storage Services

16.8.1.1.3.2.Processing Services

16.8.1.1.3.3.Transport Services

16.8.1.1.3.4.Supply Services

16.8.1.1.4.Software

16.8.1.2.China Biobanks Market Revenue (US$ Mn) and Forecasts, By Sample Type
16.8.1.2.1.Blood Products

16.8.1.2.2.Human Tissues

16.8.1.2.3.Cell Lines

16.8.1.2.4.Nucleic Acids

16.8.1.2.5.Biological Fluids

16.8.1.2.6.Human Waste Product

16.8.1.3.China Biobanks Market Revenue (US$ Mn) and Forecasts, By Storage Type
16.8.1.3.1.Manual Storage

16.8.1.3.2.Automated Storage

16.8.1.4.China Biobanks Market Revenue (US$ Mn) and Forecasts, By Ownership
16.8.1.4.1.Universities

16.8.1.4.2.National/ Regional Agencies

16.8.1.4.3.Non-Profit Organization

16.8.1.4.4.Private Organization

16.8.1.5.China Biobanks Market Revenue (US$ Mn) and Forecasts, By Application
16.8.1.5.1.Regenerative Medicine

16.8.1.5.2.Life Science Research

16.8.1.5.3.Clinical Research

16.8.1.6.China Biobanks Market Revenue (US$ Mn) and Forecasts, By End-User
16.8.1.6.1.Pharmaceutical and Biotechnology Companies and CROs

16.8.1.6.2.Academic and Research Institutes

16.8.1.6.3.Hospitals

16.8.2.Japan
16.8.2.1.Japan Biobanks Market Revenue (US$ Mn) and Forecasts, By Product and Services
16.8.2.1.1.Equipment
16.8.2.1.1.1.Storage Equipment

16.8.2.1.1.2.Sample Analysis Equipment

16.8.2.1.1.3.Sample Processing Equipment

16.8.2.1.1.4.Sample Transport Equipment

16.8.2.1.2.Consumables
16.8.2.1.2.1.Storage Consumables

16.8.2.1.2.2.Analysis Consumables

16.8.2.1.2.3.Processing Consumables

16.8.2.1.2.4.Collection Consumables

16.8.2.1.3.Services
16.8.2.1.3.1.Storage Services

16.8.2.1.3.2.Processing Services

16.8.2.1.3.3.Transport Services

16.8.2.1.3.4.Supply Services

16.8.2.1.4.Software

16.8.2.2.Japan Biobanks Market Revenue (US$ Mn) and Forecasts, By Sample Type
16.8.2.2.1.Blood Products

16.8.2.2.2.Human Tissues

16.8.2.2.3.Cell Lines

16.8.2.2.4.Nucleic Acids

16.8.2.2.5.Biological Fluids

16.8.2.2.6.Human Waste Product

16.8.2.3.Japan Biobanks Market Revenue (US$ Mn) and Forecasts, By Storage Type
16.8.2.3.1.Manual Storage

16.8.2.3.2.Automated Storage

16.8.2.4.Japan Biobanks Market Revenue (US$ Mn) and Forecasts, By Ownership
16.8.2.4.1.Universities

16.8.2.4.2.National/ Regional Agencies

16.8.2.4.3.Non-Profit Organization

16.8.2.4.4.Private Organization

16.8.2.5.Japan Biobanks Market Revenue (US$ Mn) and Forecasts, By Application
16.8.2.5.1.Regenerative Medicine

16.8.2.5.2.Life Science Research

16.8.2.5.3.Clinical Research

16.8.2.6.Japan Biobanks Market Revenue (US$ Mn) and Forecasts, By End-User
16.8.2.6.1.Pharmaceutical and Biotechnology Companies and CROs

16.8.2.6.2.Academic and Research Institutes

16.8.2.6.3.Hospitals

16.8.3.India
16.8.3.1.India Biobanks Market Revenue (US$ Mn) and Forecasts, By Product and Services
16.8.3.1.1.Equipment
16.8.3.1.1.1.Storage Equipment

16.8.3.1.1.2.Sample Analysis Equipment

16.8.3.1.1.3.Sample Processing Equipment

16.8.3.1.1.4.Sample Transport Equipment

16.8.3.1.2.Consumables
16.8.3.1.2.1.Storage Consumables

16.8.3.1.2.2.Analysis Consumables

16.8.3.1.2.3.Processing Consumables

16.8.3.1.2.4.Collection Consumables

16.8.3.1.3.Services
16.8.3.1.3.1.Storage Services

16.8.3.1.3.2.Processing Services

16.8.3.1.3.3.Transport Services

16.8.3.1.3.4.Supply Services

16.8.3.1.4.Software

16.8.3.2.India Biobanks Market Revenue (US$ Mn) and Forecasts, By Sample Type
16.8.3.2.1.Blood Products

16.8.3.2.2.Human Tissues

16.8.3.2.3.Cell Lines

16.8.3.2.4.Nucleic Acids

16.8.3.2.5.Biological Fluids

16.8.3.2.6.Human Waste Product

16.8.3.3.India Biobanks Market Revenue (US$ Mn) and Forecasts, By Storage Type
16.8.3.3.1.Manual Storage

16.8.3.3.2.Automated Storage

16.8.3.4.India Biobanks Market Revenue (US$ Mn) and Forecasts, By Ownership
16.8.3.4.1.Universities

16.8.3.4.2.National/ Regional Agencies

16.8.3.4.3.Non-Profit Organization

16.8.3.4.4.Private Organization

16.8.3.5.India Biobanks Market Revenue (US$ Mn) and Forecasts, By Application
16.8.3.5.1.Regenerative Medicine

16.8.3.5.2.Life Science Research

16.8.3.5.3.Clinical Research

16.8.3.6.India Biobanks Market Revenue (US$ Mn) and Forecasts, By End-User
16.8.3.6.1.Pharmaceutical and Biotechnology Companies and CROs

16.8.3.6.2.Academic and Research Institutes

16.8.3.6.3.Hospitals

16.8.4.New Zealand
16.8.4.1.New Zealand Biobanks Market Revenue (US$ Mn) and Forecasts, By Product and Services
16.8.4.1.1.Equipment
16.8.4.1.1.1.Storage Equipment

16.8.4.1.1.2.Sample Analysis Equipment

16.8.4.1.1.3.Sample Processing Equipment

16.8.4.1.1.4.Sample Transport Equipment

16.8.4.1.2.Consumables
16.8.4.1.2.1.Storage Consumables

16.8.4.1.2.2.Analysis Consumables

16.8.4.1.2.3.Processing Consumables

16.8.4.1.2.4.Collection Consumables

16.8.4.1.3.Services
16.8.4.1.3.1.Storage Services

16.8.4.1.3.2.Processing Services

16.8.4.1.3.3.Transport Services

16.8.4.1.3.4.Supply Services

16.8.4.1.4.Software

16.8.4.2.New Zealand Biobanks Market Revenue (US$ Mn) and Forecasts, By Sample Type
16.8.4.2.1.Blood Products

16.8.4.2.2.Human Tissues

16.8.4.2.3.Cell Lines

16.8.4.2.4.Nucleic Acids

16.8.4.2.5.Biological Fluids

16.8.4.2.6.Human Waste Product

16.8.4.3.New Zealand Biobanks Market Revenue (US$ Mn) and Forecasts, By Storage Type
16.8.4.3.1.Manual Storage

16.8.4.3.2.Automated Storage

16.8.4.4.New Zealand Biobanks Market Revenue (US$ Mn) and Forecasts, By Ownership
16.8.4.4.1.Universities

16.8.4.4.2.National/ Regional Agencies

16.8.4.4.3.Non-Profit Organization

16.8.4.4.4.Private Organization

16.8.4.5.New Zealand Biobanks Market Revenue (US$ Mn) and Forecasts, By Application
16.8.4.5.1.Regenerative Medicine

16.8.4.5.2.Life Science Research

16.8.4.5.3.Clinical Research

16.8.4.6.New Zealand Biobanks Market Revenue (US$ Mn) and Forecasts, By End-User
16.8.4.6.1.Pharmaceutical and Biotechnology Companies and CROs

16.8.4.6.2.Academic and Research Institutes

16.8.4.6.3.Hospitals

16.8.5.Australia
16.8.5.1.Australia Biobanks Market Revenue (US$ Mn) and Forecasts, By Product and Services
16.8.5.1.1.Equipment
16.8.5.1.1.1.Storage Equipment

16.8.5.1.1.2.Sample Analysis Equipment

16.8.5.1.1.3.Sample Processing Equipment

16.8.5.1.1.4.Sample Transport Equipment

16.8.5.1.2.Consumables
16.8.5.1.2.1.Storage Consumables

16.8.5.1.2.2.Analysis Consumables

16.8.5.1.2.3.Processing Consumables

16.8.5.1.2.4.Collection Consumables

16.8.5.1.3.Services
16.8.5.1.3.1.Storage Services

16.8.5.1.3.2.Processing Services

16.8.5.1.3.3.Transport Services

16.8.5.1.3.4.Supply Services

16.8.5.1.4.Software

16.8.5.2.Australia Biobanks Market Revenue (US$ Mn) and Forecasts, By Sample Type
16.8.5.2.1.Blood Products

16.8.5.2.2.Human Tissues

16.8.5.2.3.Cell Lines

16.8.5.2.4.Nucleic Acids

16.8.5.2.5.Biological Fluids

16.8.5.2.6.Human Waste Product

16.8.5.3.Australia Biobanks Market Revenue (US$ Mn) and Forecasts, By Storage Type
16.8.5.3.1.Manual Storage

16.8.5.3.2.Automated Storage

16.8.5.4.Australia Biobanks Market Revenue (US$ Mn) and Forecasts, By Ownership
16.8.5.4.1.Universities

16.8.5.4.2.National/ Regional Agencies

16.8.5.4.3.Non-Profit Organization

16.8.5.4.4.Private Organization

16.8.5.5.Australia Biobanks Market Revenue (US$ Mn) and Forecasts, By Application
16.8.5.5.1.Regenerative Medicine

16.8.5.5.2.Life Science Research

16.8.5.5.3.Clinical Research

16.8.5.6.Australia Biobanks Market Revenue (US$ Mn) and Forecasts, By End-User
16.8.5.6.1.Pharmaceutical and Biotechnology Companies and CROs

16.8.5.6.2.Academic and Research Institutes

16.8.5.6.3.Hospitals

16.8.6.South Korea
16.8.6.1.South Korea Biobanks Market Revenue (US$ Mn) and Forecasts, By Product and Services
16.8.6.1.1.Equipment
16.8.6.1.1.1.Storage Equipment

16.8.6.1.1.2.Sample Analysis Equipment

16.8.6.1.1.3.Sample Processing Equipment

16.8.6.1.1.4.Sample Transport Equipment

16.8.6.1.2.Consumables
16.8.6.1.2.1.Storage Consumables

16.8.6.1.2.2.Analysis Consumables

16.8.6.1.2.3.Processing Consumables

16.8.6.1.2.4.Collection Consumables

16.8.6.1.3.Services
16.8.6.1.3.1.Storage Services

16.8.6.1.3.2.Processing Services

16.8.6.1.3.3.Transport Services

16.8.6.1.3.4.Supply Services

16.8.6.1.4.Software

16.8.6.2.South Korea Biobanks Market Revenue (US$ Mn) and Forecasts, By Sample Type
16.8.6.2.1.Blood Products

16.8.6.2.2.Human Tissues

16.8.6.2.3.Cell Lines

16.8.6.2.4.Nucleic Acids

16.8.6.2.5.Biological Fluids

16.8.6.2.6.Human Waste Product

16.8.6.3.South Korea Biobanks Market Revenue (US$ Mn) and Forecasts, By Storage Type
16.8.6.3.1.Manual Storage

16.8.6.3.2.Automated Storage

16.8.6.4.South Korea Biobanks Market Revenue (US$ Mn) and Forecasts, By Ownership
16.8.6.4.1.Universities

16.8.6.4.2.National/ Regional Agencies

16.8.6.4.3.Non-Profit Organization

16.8.6.4.4.Private Organization

16.8.6.5.South Korea Biobanks Market Revenue (US$ Mn) and Forecasts, By Application
16.8.6.5.1.Regenerative Medicine

16.8.6.5.2.Life Science Research

16.8.6.5.3.Clinical Research

16.8.6.6.South Korea Biobanks Market Revenue (US$ Mn) and Forecasts, By End-User
16.8.6.6.1.Pharmaceutical and Biotechnology Companies and CROs

16.8.6.6.2.Academic and Research Institutes

16.8.6.6.3.Hospitals

16.8.7.Southeast Asia
16.8.7.1.Southeast Asia Biobanks Market Revenue (US$ Mn) and Forecasts, By Product and Services
16.8.7.1.1.Equipment
16.8.7.1.1.1.Storage Equipment

16.8.7.1.1.2.Sample Analysis Equipment

16.8.7.1.1.3.Sample Processing Equipment

16.8.7.1.1.4.Sample Transport Equipment

16.8.7.1.2.Consumables
16.8.7.1.2.1.Storage Consumables

16.8.7.1.2.2.Analysis Consumables

16.8.7.1.2.3.Processing Consumables

16.8.7.1.2.4.Collection Consumables

16.8.7.1.3.Services
16.8.7.1.3.1.Storage Services

16.8.7.1.3.2.Processing Services

16.8.7.1.3.3.Transport Services

16.8.7.1.3.4.Supply Services

16.8.7.1.4.Software

16.8.7.2.Southeast Asia Biobanks Market Revenue (US$ Mn) and Forecasts, By Sample Type
16.8.7.2.1.Blood Products

16.8.7.2.2.Human Tissues

16.8.7.2.3.Cell Lines

16.8.7.2.4.Nucleic Acids

16.8.7.2.5.Biological Fluids

16.8.7.2.6.Human Waste Product

16.8.7.3.Southeast Asia Biobanks Market Revenue (US$ Mn) and Forecasts, By Storage Type
16.8.7.3.1.Manual Storage

16.8.7.3.2.Automated Storage

16.8.7.4.Southeast Asia Biobanks Market Revenue (US$ Mn) and Forecasts, By Ownership
16.8.7.4.1.Universities

16.8.7.4.2.National/ Regional Agencies

16.8.7.4.3.Non-Profit Organization

16.8.7.4.4.Private Organization

16.8.7.5.Southeast Asia Biobanks Market Revenue (US$ Mn) and Forecasts, By Application
16.8.7.5.1.Regenerative Medicine

16.8.7.5.2.Life Science Research

16.8.7.5.3.Clinical Research

16.8.7.6.Southeast Asia Biobanks Market Revenue (US$ Mn) and Forecasts, By End-User
16.8.7.6.1.Pharmaceutical and Biotechnology Companies and CROs

16.8.7.6.2.Academic and Research Institutes

16.8.7.6.3.Hospitals

16.8.7.7.Southeast Asia Biobanks Market Revenue (US$ Mn) and Forecasts, By Country
16.8.7.7.1.Indonesia

16.8.7.7.2.Thailand

16.8.7.7.3.Malaysia

16.8.7.7.4.Singapore

16.8.7.7.5.Rest of Southeast Asia

16.8.8.Rest of Asia Pacific
16.8.8.1.Rest of Asia Pacific Biobanks Market Revenue (US$ Mn) and Forecasts, By Product and Services
16.8.8.1.1.Equipment
16.8.8.1.1.1.Storage Equipment

16.8.8.1.1.2.Sample Analysis Equipment

16.8.8.1.1.3.Sample Processing Equipment

16.8.8.1.1.4.Sample Transport Equipment

16.8.8.1.2.Consumables
16.8.8.1.2.1.Storage Consumables

16.8.8.1.2.2.Analysis Consumables

16.8.8.1.2.3.Processing Consumables

16.8.8.1.2.4.Collection Consumables

16.8.8.1.3.Services
16.8.8.1.3.1.Storage Services

16.8.8.1.3.2.Processing Services

16.8.8.1.3.3.Transport Services

16.8.8.1.3.4.Supply Services

16.8.8.1.4.Software

16.8.8.2.Rest of Asia Pacific Biobanks Market Revenue (US$ Mn) and Forecasts, By Sample Type
16.8.8.2.1.Blood Products

16.8.8.2.2.Human Tissues

16.8.8.2.3.Cell Lines

16.8.8.2.4.Nucleic Acids

16.8.8.2.5.Biological Fluids

16.8.8.2.6.Human Waste Product

16.8.8.3.Rest of Asia Pacific Biobanks Market Revenue (US$ Mn) and Forecasts, By Storage Type
16.8.8.3.1.Manual Storage

16.8.8.3.2.Automated Storage

16.8.8.4.Rest of Asia Pacific Biobanks Market Revenue (US$ Mn) and Forecasts, By Ownership
16.8.8.4.1.Universities

16.8.8.4.2.National/ Regional Agencies

16.8.8.4.3.Non-Profit Organization

16.8.8.4.4.Private Organization

16.8.8.5.Rest of Asia Pacific Biobanks Market Revenue (US$ Mn) and Forecasts, By Application
16.8.8.5.1.Regenerative Medicine

16.8.8.5.2.Life Science Research

16.8.8.5.3.Clinical Research

16.8.8.6.Rest of Asia Pacific Biobanks Market Revenue (US$ Mn) and Forecasts, By End-User
16.8.8.6.1.Pharmaceutical and Biotechnology Companies and CROs

16.8.8.6.2.Academic and Research Institutes

16.8.8.6.3.Hospitals

16.9.Key Segment for Channeling Investments
16.9.1.By Country

16.9.2.By Product and Services

16.9.3.By Sample Type

16.9.4.By Storage Type

16.9.5.By Ownership

16.9.6.By Application

16.9.7.By End-User

17.Middle East and Africa Biobanks Market Analysis and Forecasts, 2024 – 2034
17.1.Overview
17.1.1.Middle East and Africa Biobanks Market Revenue (US$ Mn)

17.2.Middle East and Africa Biobanks Market Revenue (US$ Mn) and Forecasts, By Product and Services
17.2.1.Equipment
17.2.1.1.Storage Equipment

17.2.1.2.Sample Analysis Equipment

17.2.1.3.Sample Processing Equipment

17.2.1.4.Sample Transport Equipment

17.2.2.Consumables
17.2.2.1.Storage Consumables

17.2.2.2.Analysis Consumables

17.2.2.3.Processing Consumables

17.2.2.4.Collection Consumables

17.2.3.Services
17.2.3.1.Storage Services

17.2.3.2.Processing Services

17.2.3.3.Transport Services

17.2.3.4.Supply Services

17.2.4.Software

17.3.Middle East and Africa Biobanks Market Revenue (US$ Mn) and Forecasts, By Sample Type
17.3.1.Blood Products

17.3.2.Human Tissues

17.3.3.Cell Lines

17.3.4.Nucleic Acids

17.3.5.Biological Fluids

17.3.6.Human Waste Product

17.4.Middle East and Africa Biobanks Market Revenue (US$ Mn) and Forecasts, By Storage Type
17.4.1.Manual Storage

17.4.2.Automated Storage

17.5.Middle East and Africa Biobanks Market Revenue (US$ Mn) and Forecasts, By Ownership
17.5.1.Universities

17.5.2.National/ Regional Agencies

17.5.3.Non-Profit Organization

17.5.4.Private Organization

17.6.Middle East and Africa Biobanks Market Revenue (US$ Mn) and Forecasts, By Application
17.6.1.Regenerative Medicine

17.6.2.Life Science Research

17.6.3.Clinical Research

17.7.Middle East and Africa Biobanks Market Revenue (US$ Mn) and Forecasts, By End-User
17.7.1.Pharmaceutical and Biotechnology Companies and CROs

17.7.2.Academic and Research Institutes

17.7.3.Hospitals

17.8.Middle East and Africa Biobanks Market Revenue (US$ Mn) and Forecasts, By Country
17.8.1.Saudi Arabia
17.8.1.1.Saudi Arabia Biobanks Market Revenue (US$ Mn) and Forecasts, By Product and Services
17.8.1.1.1.Equipment
17.8.1.1.1.1.Storage Equipment

17.8.1.1.1.2.Sample Analysis Equipment

17.8.1.1.1.3.Sample Processing Equipment

17.8.1.1.1.4.Sample Transport Equipment

17.8.1.1.2.Consumables
17.8.1.1.2.1.Storage Consumables

17.8.1.1.2.2.Analysis Consumables

17.8.1.1.2.3.Processing Consumables

17.8.1.1.2.4.Collection Consumables

17.8.1.1.3.Services
17.8.1.1.3.1.Storage Services

17.8.1.1.3.2.Processing Services

17.8.1.1.3.3.Transport Services

17.8.1.1.3.4.Supply Services

17.8.1.1.4.Software

17.8.1.2.Saudi Arabia Biobanks Market Revenue (US$ Mn) and Forecasts, By Sample Type
17.8.1.2.1.Blood Products

17.8.1.2.2.Human Tissues

17.8.1.2.3.Cell Lines

17.8.1.2.4.Nucleic Acids

17.8.1.2.5.Biological Fluids

17.8.1.2.6.Human Waste Product

17.8.1.3.Saudi Arabia Biobanks Market Revenue (US$ Mn) and Forecasts, By Storage Type
17.8.1.3.1.Manual Storage

17.8.1.3.2.Automated Storage

17.8.1.4.Saudi Arabia Biobanks Market Revenue (US$ Mn) and Forecasts, By Ownership
17.8.1.4.1.Universities

17.8.1.4.2.National/ Regional Agencies

17.8.1.4.3.Non-Profit Organization

17.8.1.4.4.Private Organization

17.8.1.5.Saudi Arabia Biobanks Market Revenue (US$ Mn) and Forecasts, By Application
17.8.1.5.1.Regenerative Medicine

17.8.1.5.2.Life Science Research

17.8.1.5.3.Clinical Research

17.8.1.6.Saudi Arabia Biobanks Market Revenue (US$ Mn) and Forecasts, By End-User
17.8.1.6.1.Pharmaceutical and Biotechnology Companies and CROs

17.8.1.6.2.Academic and Research Institutes

17.8.1.6.3.Hospitals

17.8.2.UAE
17.8.2.1.UAE Biobanks Market Revenue (US$ Mn) and Forecasts, By Product and Services
17.8.2.1.1.Equipment
17.8.2.1.1.1.Storage Equipment

17.8.2.1.1.2.Sample Analysis Equipment

17.8.2.1.1.3.Sample Processing Equipment

17.8.2.1.1.4.Sample Transport Equipment

17.8.2.1.2.Consumables
17.8.2.1.2.1.Storage Consumables

17.8.2.1.2.2.Analysis Consumables

17.8.2.1.2.3.Processing Consumables

17.8.2.1.2.4.Collection Consumables

17.8.2.1.3.Services
17.8.2.1.3.1.Storage Services

17.8.2.1.3.2.Processing Services

17.8.2.1.3.3.Transport Services

17.8.2.1.3.4.Supply Services

17.8.2.1.4.Software

17.8.2.2.UAE Biobanks Market Revenue (US$ Mn) and Forecasts, By Sample Type
17.8.2.2.1.Blood Products

17.8.2.2.2.Human Tissues

17.8.2.2.3.Cell Lines

17.8.2.2.4.Nucleic Acids

17.8.2.2.5.Biological Fluids

17.8.2.2.6.Human Waste Product

17.8.2.3.UAE Biobanks Market Revenue (US$ Mn) and Forecasts, By Storage Type
17.8.2.3.1.Manual Storage

17.8.2.3.2.Automated Storage

17.8.2.4.UAE Biobanks Market Revenue (US$ Mn) and Forecasts, By Ownership
17.8.2.4.1.Universities

17.8.2.4.2.National/ Regional Agencies

17.8.2.4.3.Non-Profit Organization

17.8.2.4.4.Private Organization

17.8.2.5.UAE Biobanks Market Revenue (US$ Mn) and Forecasts, By Application
17.8.2.5.1.Regenerative Medicine

17.8.2.5.2.Life Science Research

17.8.2.5.3.Clinical Research

17.8.2.6.UAE Biobanks Market Revenue (US$ Mn) and Forecasts, By End-User
17.8.2.6.1.Pharmaceutical and Biotechnology Companies and CROs

17.8.2.6.2.Academic and Research Institutes

17.8.2.6.3.Hospitals

17.8.3.Egypt
17.8.3.1.Egypt Biobanks Market Revenue (US$ Mn) and Forecasts, By Product and Services
17.8.3.1.1.Equipment
17.8.3.1.1.1.Storage Equipment

17.8.3.1.1.2.Sample Analysis Equipment

17.8.3.1.1.3.Sample Processing Equipment

17.8.3.1.1.4.Sample Transport Equipment

17.8.3.1.2.Consumables
17.8.3.1.2.1.Storage Consumables

17.8.3.1.2.2.Analysis Consumables

17.8.3.1.2.3.Processing Consumables

17.8.3.1.2.4.Collection Consumables

17.8.3.1.3.Services
17.8.3.1.3.1.Storage Services

17.8.3.1.3.2.Processing Services

17.8.3.1.3.3.Transport Services

17.8.3.1.3.4.Supply Services

17.8.3.1.4.Software

17.8.3.2.Egypt Biobanks Market Revenue (US$ Mn) and Forecasts, By Sample Type
17.8.3.2.1.Blood Products

17.8.3.2.2.Human Tissues

17.8.3.2.3.Cell Lines

17.8.3.2.4.Nucleic Acids

17.8.3.2.5.Biological Fluids

17.8.3.2.6.Human Waste Product

17.8.3.3.Egypt Biobanks Market Revenue (US$ Mn) and Forecasts, By Storage Type
17.8.3.3.1.Manual Storage

17.8.3.3.2.Automated Storage

17.8.3.4.Egypt Biobanks Market Revenue (US$ Mn) and Forecasts, By Ownership
17.8.3.4.1.Universities

17.8.3.4.2.National/ Regional Agencies

17.8.3.4.3.Non-Profit Organization

17.8.3.4.4.Private Organization

17.8.3.5.Egypt Biobanks Market Revenue (US$ Mn) and Forecasts, By Application
17.8.3.5.1.Regenerative Medicine

17.8.3.5.2.Life Science Research

17.8.3.5.3.Clinical Research

17.8.3.6.Egypt Biobanks Market Revenue (US$ Mn) and Forecasts, By End-User
17.8.3.6.1.Pharmaceutical and Biotechnology Companies and CROs

17.8.3.6.2.Academic and Research Institutes

17.8.3.6.3.Hospitals

17.8.4.Kuwait
17.8.4.1.Kuwait Biobanks Market Revenue (US$ Mn) and Forecasts, By Product and Services
17.8.4.1.1.Equipment
17.8.4.1.1.1.Storage Equipment

17.8.4.1.1.2.Sample Analysis Equipment

17.8.4.1.1.3.Sample Processing Equipment

17.8.4.1.1.4.Sample Transport Equipment

17.8.4.1.2.Consumables
17.8.4.1.2.1.Storage Consumables

17.8.4.1.2.2.Analysis Consumables

17.8.4.1.2.3.Processing Consumables

17.8.4.1.2.4.Collection Consumables

17.8.4.1.3.Services
17.8.4.1.3.1.Storage Services

17.8.4.1.3.2.Processing Services

17.8.4.1.3.3.Transport Services

17.8.4.1.3.4.Supply Services

17.8.4.1.4.Software

17.8.4.2.Kuwait Biobanks Market Revenue (US$ Mn) and Forecasts, By Sample Type
17.8.4.2.1.Blood Products

17.8.4.2.2.Human Tissues

17.8.4.2.3.Cell Lines

17.8.4.2.4.Nucleic Acids

17.8.4.2.5.Biological Fluids

17.8.4.2.6.Human Waste Product

17.8.4.3.Kuwait Biobanks Market Revenue (US$ Mn) and Forecasts, By Storage Type
17.8.4.3.1.Manual Storage

17.8.4.3.2.Automated Storage

17.8.4.4.Kuwait Biobanks Market Revenue (US$ Mn) and Forecasts, By Ownership
17.8.4.4.1.Universities

17.8.4.4.2.National/ Regional Agencies

17.8.4.4.3.Non-Profit Organization

17.8.4.4.4.Private Organization

17.8.4.5.Kuwait Biobanks Market Revenue (US$ Mn) and Forecasts, By Application
17.8.4.5.1.Regenerative Medicine

17.8.4.5.2.Life Science Research

17.8.4.5.3.Clinical Research

17.8.4.6.Kuwait Biobanks Market Revenue (US$ Mn) and Forecasts, By End-User
17.8.4.6.1.Pharmaceutical and Biotechnology Companies and CROs

17.8.4.6.2.Academic and Research Institutes

17.8.4.6.3.Hospitals

17.8.5.South Africa
17.8.5.1.South Africa Biobanks Market Revenue (US$ Mn) and Forecasts, By Product and Services
17.8.5.1.1.Equipment
17.8.5.1.1.1.Storage Equipment

17.8.5.1.1.2.Sample Analysis Equipment

17.8.5.1.1.3.Sample Processing Equipment

17.8.5.1.1.4.Sample Transport Equipment

17.8.5.1.2.Consumables
17.8.5.1.2.1.Storage Consumables

17.8.5.1.2.2.Analysis Consumables

17.8.5.1.2.3.Processing Consumables

17.8.5.1.2.4.Collection Consumables

17.8.5.1.3.Services
17.8.5.1.3.1.Storage Services

17.8.5.1.3.2.Processing Services

17.8.5.1.3.3.Transport Services

17.8.5.1.3.4.Supply Services

17.8.5.1.4.Software

17.8.5.2.South Africa Biobanks Market Revenue (US$ Mn) and Forecasts, By Sample Type
17.8.5.2.1.Blood Products

17.8.5.2.2.Human Tissues

17.8.5.2.3.Cell Lines

17.8.5.2.4.Nucleic Acids

17.8.5.2.5.Biological Fluids

17.8.5.2.6.Human Waste Product

17.8.5.3.South Africa Biobanks Market Revenue (US$ Mn) and Forecasts, By Storage Type
17.8.5.3.1.Manual Storage

17.8.5.3.2.Automated Storage

17.8.5.4.South Africa Biobanks Market Revenue (US$ Mn) and Forecasts, By Ownership
17.8.5.4.1.Universities

17.8.5.4.2.National/ Regional Agencies

17.8.5.4.3.Non-Profit Organization

17.8.5.4.4.Private Organization

17.8.5.5.South Africa Biobanks Market Revenue (US$ Mn) and Forecasts, By Application
17.8.5.5.1.Regenerative Medicine

17.8.5.5.2.Life Science Research

17.8.5.5.3.Clinical Research

17.8.5.6.South Africa Biobanks Market Revenue (US$ Mn) and Forecasts, By End-User
17.8.5.6.1.Pharmaceutical and Biotechnology Companies and CROs

17.8.5.6.2.Academic and Research Institutes

17.8.5.6.3.Hospitals

17.8.6.Rest of Middle East & Africa
17.8.6.1.Rest of Middle East & Africa Biobanks Market Revenue (US$ Mn) and Forecasts, By Product and Services
17.8.6.1.1.Equipment
17.8.6.1.1.1.Storage Equipment

17.8.6.1.1.2.Sample Analysis Equipment

17.8.6.1.1.3.Sample Processing Equipment

17.8.6.1.1.4.Sample Transport Equipment

17.8.6.1.2.Consumables
17.8.6.1.2.1.Storage Consumables

17.8.6.1.2.2.Analysis Consumables

17.8.6.1.2.3.Processing Consumables

17.8.6.1.2.4.Collection Consumables

17.8.6.1.3.Services
17.8.6.1.3.1.Storage Services

17.8.6.1.3.2.Processing Services

17.8.6.1.3.3.Transport Services

17.8.6.1.3.4.Supply Services

17.8.6.1.4.Software

17.8.6.2.Rest of Middle East & Africa Biobanks Market Revenue (US$ Mn) and Forecasts, By Sample Type
17.8.6.2.1.Blood Products

17.8.6.2.2.Human Tissues

17.8.6.2.3.Cell Lines

17.8.6.2.4.Nucleic Acids

17.8.6.2.5.Biological Fluids

17.8.6.2.6.Human Waste Product

17.8.6.3.Rest of Middle East & Africa Biobanks Market Revenue (US$ Mn) and Forecasts, By Storage Type
17.8.6.3.1.Manual Storage

17.8.6.3.2.Automated Storage

17.8.6.4.Rest of Middle East & Africa Biobanks Market Revenue (US$ Mn) and Forecasts, By Ownership
17.8.6.4.1.Universities

17.8.6.4.2.National/ Regional Agencies

17.8.6.4.3.Non-Profit Organization

17.8.6.4.4.Private Organization

17.8.6.5.Rest of Middle East & Africa Biobanks Market Revenue (US$ Mn) and Forecasts, By Application
17.8.6.5.1.Regenerative Medicine

17.8.6.5.2.Life Science Research

17.8.6.5.3.Clinical Research

17.8.6.6.Rest of Middle East & Africa Biobanks Market Revenue (US$ Mn) and Forecasts, By End-User
17.8.6.6.1.Pharmaceutical and Biotechnology Companies and CROs

17.8.6.6.2.Academic and Research Institutes

17.8.6.6.3.Hospitals

17.9.Key Segment for Channeling Investments
17.9.1.By Country

17.9.2.By Product and Services

17.9.3.By Sample Type

17.9.4.By Storage Type

17.9.5.By Ownership

17.9.6.By Application

17.9.7.By End-User

18.Latin America Biobanks Market Analysis and Forecasts, 2024 – 2034
18.1.Overview
18.1.1.Latin America Biobanks Market Revenue (US$ Mn)

18.2.Latin America Biobanks Market Revenue (US$ Mn) and Forecasts, By Product and Services
18.2.1.Equipment
18.2.1.1.Storage Equipment

18.2.1.2.Sample Analysis Equipment

18.2.1.3.Sample Processing Equipment

18.2.1.4.Sample Transport Equipment

18.2.2.Consumables
18.2.2.1.Storage Consumables

18.2.2.2.Analysis Consumables

18.2.2.3.Processing Consumables

18.2.2.4.Collection Consumables

18.2.3.Services
18.2.3.1.Storage Services

18.2.3.2.Processing Services

18.2.3.3.Transport Services

18.2.3.4.Supply Services

18.2.4.Software

18.3.Latin America Biobanks Market Revenue (US$ Mn) and Forecasts, By Sample Type
18.3.1.Blood Products

18.3.2.Human Tissues

18.3.3.Cell Lines

18.3.4.Nucleic Acids

18.3.5.Biological Fluids

18.3.6.Human Waste Product

18.4.Latin America Biobanks Market Revenue (US$ Mn) and Forecasts, By Storage Type
18.4.1.Manual Storage

18.4.2.Automated Storage

18.5.Latin America Biobanks Market Revenue (US$ Mn) and Forecasts, By Ownership
18.5.1.Universities

18.5.2.National/ Regional Agencies

18.5.3.Non-Profit Organization

18.5.4.Private Organization

18.6.Latin America Biobanks Market Revenue (US$ Mn) and Forecasts, By Application
18.6.1.Regenerative Medicine

18.6.2.Life Science Research

18.6.3.Clinical Research

18.7.Latin America Biobanks Market Revenue (US$ Mn) and Forecasts, By End-User
18.7.1.Pharmaceutical and Biotechnology Companies and CROs

18.7.2.Academic and Research Institutes

18.7.3.Hospitals

18.8.Latin America Biobanks Market Revenue (US$ Mn) and Forecasts, By Country
18.8.1.Brazil
18.8.1.1.Brazil Biobanks Market Revenue (US$ Mn) and Forecasts, By Product and Services
18.8.1.1.1.Equipment
18.8.1.1.1.1.Storage Equipment

18.8.1.1.1.2.Sample Analysis Equipment

18.8.1.1.1.3.Sample Processing Equipment

18.8.1.1.1.4.Sample Transport Equipment

18.8.1.1.2.Consumables
18.8.1.1.2.1.Storage Consumables

18.8.1.1.2.2.Analysis Consumables

18.8.1.1.2.3.Processing Consumables

18.8.1.1.2.4.Collection Consumables

18.8.1.1.3.Services
18.8.1.1.3.1.Storage Services

18.8.1.1.3.2.Processing Services

18.8.1.1.3.3.Transport Services

18.8.1.1.3.4.Supply Services

18.8.1.1.4.Software

18.8.1.2.Brazil Biobanks Market Revenue (US$ Mn) and Forecasts, By Sample Type
18.8.1.2.1.Blood Products

18.8.1.2.2.Human Tissues

18.8.1.2.3.Cell Lines

18.8.1.2.4.Nucleic Acids

18.8.1.2.5.Biological Fluids

18.8.1.2.6.Human Waste Product

18.8.1.3.Brazil Biobanks Market Revenue (US$ Mn) and Forecasts, By Storage Type
18.8.1.3.1.Manual Storage

18.8.1.3.2.Automated Storage

18.8.1.4.Brazil Biobanks Market Revenue (US$ Mn) and Forecasts, By Ownership
18.8.1.4.1.Universities

18.8.1.4.2.National/ Regional Agencies

18.8.1.4.3.Non-Profit Organization

18.8.1.4.4.Private Organization

18.8.1.5.Brazil Biobanks Market Revenue (US$ Mn) and Forecasts, By Application
18.8.1.5.1.Regenerative Medicine

18.8.1.5.2.Life Science Research

18.8.1.5.3.Clinical Research

18.8.1.6.Brazil Biobanks Market Revenue (US$ Mn) and Forecasts, By End-User
18.8.1.6.1.Pharmaceutical and Biotechnology Companies and CROs

18.8.1.6.2.Academic and Research Institutes

18.8.1.6.3.Hospitals

18.8.2.Argentina
18.8.2.1.Argentina Biobanks Market Revenue (US$ Mn) and Forecasts, By Product and Services
18.8.2.1.1.Equipment
18.8.2.1.1.1.Storage Equipment

18.8.2.1.1.2.Sample Analysis Equipment

18.8.2.1.1.3.Sample Processing Equipment

18.8.2.1.1.4.Sample Transport Equipment

18.8.2.1.2.Consumables
18.8.2.1.2.1.Storage Consumables

18.8.2.1.2.2.Analysis Consumables

18.8.2.1.2.3.Processing Consumables

18.8.2.1.2.4.Collection Consumables

18.8.2.1.3.Services
18.8.2.1.3.1.Storage Services

18.8.2.1.3.2.Processing Services

18.8.2.1.3.3.Transport Services

18.8.2.1.3.4.Supply Services

18.8.2.1.4.Software

18.8.2.2.Argentina Biobanks Market Revenue (US$ Mn) and Forecasts, By Sample Type
18.8.2.2.1.Blood Products

18.8.2.2.2.Human Tissues

18.8.2.2.3.Cell Lines

18.8.2.2.4.Nucleic Acids

18.8.2.2.5.Biological Fluids

18.8.2.2.6.Human Waste Product

18.8.2.3.Argentina Biobanks Market Revenue (US$ Mn) and Forecasts, By Storage Type
18.8.2.3.1.Manual Storage

18.8.2.3.2.Automated Storage

18.8.2.4.Argentina Biobanks Market Revenue (US$ Mn) and Forecasts, By Ownership
18.8.2.4.1.Universities

18.8.2.4.2.National/ Regional Agencies

18.8.2.4.3.Non-Profit Organization

18.8.2.4.4.Private Organization

18.8.2.5.Argentina Biobanks Market Revenue (US$ Mn) and Forecasts, By Application
18.8.2.5.1.Regenerative Medicine

18.8.2.5.2.Life Science Research

18.8.2.5.3.Clinical Research

18.8.2.6.Argentina Biobanks Market Revenue (US$ Mn) and Forecasts, By End-User
18.8.2.6.1.Pharmaceutical and Biotechnology Companies and CROs

18.8.2.6.2.Academic and Research Institutes

18.8.2.6.3.Hospitals

18.8.3.Rest of Latin America
18.8.3.1.Rest of Latin America Biobanks Market Revenue (US$ Mn) and Forecasts, By Product and Services
18.8.3.1.1.Equipment
18.8.3.1.1.1.Storage Equipment

18.8.3.1.1.2.Sample Analysis Equipment

18.8.3.1.1.3.Sample Processing Equipment

18.8.3.1.1.4.Sample Transport Equipment

18.8.3.1.2.Consumables
18.8.3.1.2.1.Storage Consumables

18.8.3.1.2.2.Analysis Consumables

18.8.3.1.2.3.Processing Consumables

18.8.3.1.2.4.Collection Consumables

18.8.3.1.3.Services
18.8.3.1.3.1.Storage Services

18.8.3.1.3.2.Processing Services

18.8.3.1.3.3.Transport Services

18.8.3.1.3.4.Supply Services

18.8.3.1.4.Software

18.8.3.2.Rest of Latin America Biobanks Market Revenue (US$ Mn) and Forecasts, By Sample Type
18.8.3.2.1.Blood Products

18.8.3.2.2.Human Tissues

18.8.3.2.3.Cell Lines

18.8.3.2.4.Nucleic Acids

18.8.3.2.5.Biological Fluids

18.8.3.2.6.Human Waste Product

18.8.3.3.Rest of Latin America Biobanks Market Revenue (US$ Mn) and Forecasts, By Storage Type
18.8.3.3.1.Manual Storage

18.8.3.3.2.Automated Storage

18.8.3.4.Rest of Latin America Biobanks Market Revenue (US$ Mn) and Forecasts, By Ownership
18.8.3.4.1.Universities

18.8.3.4.2.National/ Regional Agencies

18.8.3.4.3.Non-Profit Organization

18.8.3.4.4.Private Organization

18.8.3.5.Rest of Latin America Biobanks Market Revenue (US$ Mn) and Forecasts, By Application
18.8.3.5.1.Regenerative Medicine

18.8.3.5.2.Life Science Research

18.8.3.5.3.Clinical Research

18.8.3.6.Rest of Latin America Biobanks Market Revenue (US$ Mn) and Forecasts, By End-User
18.8.3.6.1.Pharmaceutical and Biotechnology Companies and CROs

18.8.3.6.2.Academic and Research Institutes

18.8.3.6.3.Hospitals

18.9.Key Segment for Channeling Investments
18.9.1.By Country

18.9.2.By Product and Services

18.9.3.By Sample Type

18.9.4.By Storage Type

18.9.5.By Ownership

18.9.6.By Application

18.9.7.By End-User

19.Competitive Benchmarking
19.1.Brand Benchmarking

19.2.Market Share Analysis, 2023

19.3.Global Presence and Growth Strategies
19.3.1.Mergers and Acquisitions

19.3.2.Product Launches

19.3.3.Investments Trends

19.3.4.R&D Initiatives

20.Player Profiles
20.1.Avantor Inc.
20.1.1.Company Details

20.1.2.Company Overview

20.1.3.Product Offerings

20.1.4.Key Developments

20.1.5.Financial Analysis

20.1.6.SWOT Analysis

20.1.7.Business Strategies

20.2.Azenta Inc
20.2.1.Company Details

20.2.2.Company Overview

20.2.3.Product Offerings

20.2.4.Key Developments

20.2.5.Financial Analysis

20.2.6.SWOT Analysis

20.2.7.Business Strategies

20.3.Becton Dickinson and Company
20.3.1.Company Details

20.3.2.Company Overview

20.3.3.Product Offerings

20.3.4.Key Developments

20.3.5.Financial Analysis

20.3.6.SWOT Analysis

20.3.7.Business Strategies

20.4.Cryoport Inc.
20.4.1.Company Details

20.4.2.Company Overview

20.4.3.Product Offerings

20.4.4.Key Developments

20.4.5.Financial Analysis

20.4.6.SWOT Analysis

20.4.7.Business Strategies

20.5.Hamilton Company
20.5.1.Company Details

20.5.2.Company Overview

20.5.3.Product Offerings

20.5.4.Key Developments

20.5.5.Financial Analysis

20.5.6.SWOT Analysis

20.5.7.Business Strategies

20.6.Merck & Co., Inc.
20.6.1.Company Details

20.6.2.Company Overview

20.6.3.Product Offerings

20.6.4.Key Developments

20.6.5.Financial Analysis

20.6.6.SWOT Analysis

20.6.7.Business Strategies

20.7.PHC Holdings Corporation
20.7.1.Company Details

20.7.2.Company Overview

20.7.3.Product Offerings

20.7.4.Key Developments

20.7.5.Financial Analysis

20.7.6.SWOT Analysis

20.7.7.Business Strategies

20.8.Qiagen N.V.
20.8.1.Company Details

20.8.2.Company Overview

20.8.3.Product Offerings

20.8.4.Key Developments

20.8.5.Financial Analysis

20.8.6.SWOT Analysis

20.8.7.Business Strategies

20.9.Tecan Trading AG
20.9.1.Company Details

20.9.2.Company Overview

20.9.3.Product Offerings

20.9.4.Key Developments

20.9.5.Financial Analysis

20.9.6.SWOT Analysis

20.9.7.Business Strategies

20.10.Thermo Fisher Scientific, Inc.
20.10.1.Company Details

20.10.2.Company Overview

20.10.3.Product Offerings

20.10.4.Key Developments

20.10.5.Financial Analysis

20.10.6.SWOT Analysis

20.10.7.Business Strategies

20.11.Other Market Participants

21.Key Findings

.

**Exclusive for Multi-User and Enterprise User.

Global Biobanks Market

By Product & Service

  • Equipment
    • Storage Equipment
    • Sample Analysis Equipment
    • Sample Processing Equipment
    • Sample Transport Equipment
  • Consumables
    • Storage Consumables
    • Analysis Consumables
    • Processing Consumables
    • Collection Consumables
  • Services
    • Storage Services
    • Processing Services
    • Transport Services
    • Supply Services
  • Software

By Sample Type

  • Blood Products
  • Human Tissues
  • Cell Lines
  • Nucleic Acids
  • Biological Fluids
  • Human Waste product

By Storage Type

  • Manual Storage
  • Automated Storage

By Ownership

  • Universities
  • National/ Regional agencies
  • Non-Profit Organization
  • Private organization

By Application

  • Regenerative Medicine
  • Life Science Research
  • Clinical Research

By End-User

  • Pharmaceutical & Biotechnology Companies and CROs
  • Academic & Research Institutes
  • Hospitals

By Region

  • North America (U.S., Canada, Mexico, Rest of North America)
  • Europe (France, The UK, Spain, Germany, Italy, Nordic Countries (Denmark, Finland, Iceland, Sweden, Norway), Benelux Union (Belgium, The Netherlands, Luxembourg), Rest of Europe
  • Asia Pacific (China, Japan, India, New Zealand, Australia, South Korea, Southeast Asia (Indonesia, Thailand, Malaysia, Singapore, Rest of Southeast Asia), Rest of Asia Pacific
  • Middle East & Africa (Saudi Arabia, UAE, Egypt, Kuwait, South Africa, Rest of Middle East & Africa)
  • Latin America (Brazil, Argentina, Rest of Latin America)

The Niche Research approach encompasses both primary and secondary research methods to provide comprehensive insights. While primary research is the cornerstone of our studies, we also incorporate secondary research sources such as company annual reports, premium industry databases, press releases, industry journals, and white papers.

Within our primary research, we actively engage with various industry stakeholders, conducting paid interviews and surveys. Our meticulous analysis extends to every market participant in major countries, allowing us to thoroughly examine their portfolios, calculate market shares, and segment revenues.

Our data collection primarily focuses on individual countries within our research scope, enabling us to estimate regional market sizes. Typically, we employ a bottom-up approach, meticulously tracking trends in different countries. We analyze growth drivers, constraints, technological innovations, and opportunities for each country, ultimately arriving at regional figures.Our process begins by examining the growth prospects of each country. Building upon these insights, we project growth and trends for the entire region. Finally, we utilize our proprietary model to refine estimations and forecasts.

Our data validation standards are integral to ensuring the reliability and accuracy of our research findings. Here’s a breakdown of our data validation processes and the stakeholders we engage with during our primary research:

  • Supply Side Analysis: We initiate a supply side analysis by directly contacting market participants, through telephonic interviews and questionnaires containing both open-ended and close-ended questions. We gather information on their portfolios, segment revenues, developments, and growth strategies.
  • Demand Side Analysis: To gain insights into adoption trends and consumer preferences, we reach out to target customers and users (non-vendors). This information forms a vital part of the qualitative analysis section of our reports, covering market dynamics, adoption trends, consumer behavior, spending patterns, and other related aspects.
  • Consultant Insights: We tap into the expertise of our partner consultants from around the world to obtain their unique viewpoints and perspectives. Their insights contribute to a well-rounded understanding of the markets under investigation.
  • In-House Validation: To ensure data accuracy and reliability, we conduct cross-validation of data points and information through our in-house team of consultants and utilize advanced data modeling tools for thorough verification.

The forecasts we provide are based on a comprehensive assessment of various factors, including:

  • Market Trends and Past Performance (Last Five Years): We accurately analyze market trends and performance data from preceding five years to identify historical patterns and understand the market’s evolution.
  • Historical Performance and Growth of Market Participants: We assess the historical performance and growth trajectories of key market participants. This analysis provides insights into the competitive landscape and individual company strategies.
  • Market Determinants Impact Analysis (Next Eight Years): We conduct a rigorous analysis of the factors that are projected to influence the market over the next eight years. This includes assessing both internal and external determinants that can shape market dynamics.
  • Drivers and Challenges for the Forecast Period:Identify the factors expected to drive market growth during the forecast period, as well as the challenges that the industry may face. This analysis aids in deriving an accurate growth rate projection.
  • New Acquisitions, Collaborations, or Partnerships: We keep a close watch on any new acquisitions, collaborations, or partnerships within the industry. These developments can have a significant impact on market dynamics and competitiveness.
  • Macro and Micro Factors Analysis:A thorough examination of both macro-level factors (e.g., economic trends, regulatory changes) and micro-level factors (e.g., technological advancements, consumer preferences) that may influence the market during the forecast period.
  • End-User Sentiment Analysis: To understand the market from the end-user perspective, we conduct sentiment analysis. This involves assessing the sentiment, preferences, and feedback of the end-users, which can provide valuable insights into market trends.
  • Perspective of Primary Participants: Insights gathered directly from primary research participants play a crucial role in shaping our forecasts. Their perspectives and experiences provide valuable qualitative data.
  • Year-on-Year Growth Trend: We utilize a year-on-year growth trend based on historical market growth and expected future trends. This helps in formulating our growth projections, aligning them with the market’s historical performance.

Research process adopted by TNR involves multiple stages, including data collection, validation, quality checks, and presentation. It’s crucial that the data and information we provide add value to your existing market understanding and expertise. We have also established partnerships with business consulting, research, and survey organizations across regions and globally to collaborate on regional analysis and data validation, ensuring the highest level of accuracy and reliability in our reports.

 

 

Procure Comprehensive Study of

Global Biobanks Market

Online Only

  • Online Access
  • Read Only File
  • Validity 3 Months
  • Print, Copy, Paste & Download
  • PPT, Excel
  • Cost-Free Report in the Next Update
$3300
Buy Now

Single User

  • Access to One User on One System
  • Read Only File
  • Validity 6 Months
  • Limited Print,Copy, Paste
  • PPT, Excel
  • Cost-Free Report in the Next Update
$4200
Buy Now

Multi User

  • Access to Fiver Users
  • PDF File
  • Validity 1 Year
  • Upto FivePrints
  • Cost-Free Report in the Next Update
  • PPT, Excel
$6000
Buy Now

Enterprise User

  • Access to Unlimited Users
  • PDF, PPT, Excel
  • Unlimited Validity, Prints&Downloads
  • 1 Hour Cost-Free & Dedicated Analyst Support
  • 10% Cost-Free Customization
  • Cost-Free Report Update Twice in a Year
  • Recommendations for Business Strategies
  • Authorization to Quote TNR, The Niche Research
$7300
Buy Now

Library Access

  • Online Access to Content Publications
  • Access Player Profiles Online
  • Get Immediate Access to Newly Added Content
  • Acquire 12 PDF Downloads
  • Acquire 5 Excel Data Sets
  • Gain Access to 290+ PDFs of Company Profiles
  • Round-the-clock Email and Phone Assistance
  • Dashboard Usage and Trends
  • Renewal & Upgrade Assistance
  • Assessing Customization Options and Alerts for New Reports
$10788
Buy Now
*Taxes/Fees, if applicable will be added during checkout. All prices in USD

Why TNR The Niche Research?

  • Unwavering Commitment to Excellence

  • Veteran Team of Researchers

  • Accurate and Timely Insights

  • Ethical Practices and Customized Service

  • Uninterrupted Availability Around the Clock